Benign neoplasm: Caecum

CD2_BENIGN_CAECUM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D12.0& Hospital discharge: ICD-8 — 21132 Cause of death: ICD-10 — D12.0& Cause of death: ICD-8 — 21132 2 out of 7 registries used, show all original rules.	4873
4. Check minimum number of events None	4873
5. Include endpoints None	4873
6. Filter based on genotype QC (FinnGen only)	4386

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D12
Name in latin: Neoplasma benignum caeci

NAME	CD2_BENIGN_CAECUM
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D120
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	21132
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D120
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	21132
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Caecum based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17590	9035	8500
Only index persons	16774	8728	8046
Unadjusted period prevalence (%)
Whole population	0.25	0.26	0.24
Only index persons	0.31	0.32	0.31
Median age at first event (years)
Whole population	69.48	69.23	69.74
Only index persons	69.27	69.08	69.49

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4386	2259	2127
Unadjusted period prevalence (%)	0.89	0.80	0.98
Median age at first event (years)	69.13	68.14	70.17

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4520: Matched controls
45200

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

4.0

307.7

1867

6743

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

6.2

307.7

806

1537

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

10.1

307.7

907

1099

UJF32

NOMESCO Finland

Coloscopy

12.1

307.7

3419

9207

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

13.5

307.7

435

355

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

158532.7

307.7

4499

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

12.8

307.7

442

380

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

8.8

307.7

771

1029

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

17.6

307.7

1068

780

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

17.5

307.7

1818

1676

UJF30

NOMESCO Finland

Ileoscopy through colon

5.5

307.7

1288

3032

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

16.2

307.7

775

570

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.1

296.5

2176

10446

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

11.5

273.2

290

268

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

95.8

197.7

103

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.2

153.2

684

2364

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

136.8

1648

9203

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

130.6

1912

11486

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

14.3

128.1

117

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

6.7

127.4

206

319

K63.5

ICD-10 Finland

Polyp of colon

5.2

126.2

268

539

JFA42

NOMESCO Finland

Endoscopic injection in colon

14.8

111.9

100

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

7.0

90.7

140

206

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.0

88.8

419

1476

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.9

87.6

434

1571

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

87.5

764

3644

D12.1

ICD-10 Finland

Benign neoplasm: Appendix

14.4

82.7

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

75.9

828

4302

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

75.8

1225

7320

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

72.8

2589

19530

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.5

70.6

478

2022

K64.0

ICD-10 Finland

First degree haemorrhoids

4.2

68.8

187

458

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

8.9

68.3

A02BC02

ATC

pantoprazole; systemic

1.8

67.6

3346

27476

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

66.0

1025

6006

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

63.4

518

2381

B01AB05

ATC

enoxaparin; parenteral

1.7

62.7

1688

11625

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

60.8

703

3707

JFA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in colon

14.9

59.6

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

57.0

503

2383

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

7.1

56.7

121

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

56.1

566

2830

N02BE01

ATC

paracetamol; systemic, rectal

2.4

55.2

4153

37412

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

9.3

54.8

8263/2-C18.0

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of cecum

86.9

54.0

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

9.1

53.4

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

3.5

52.0

185

547

JN4AD

NOMESCO Finland

Body CT examination

1.9

49.7

715

4045

UJH02

NOMESCO Finland

Anoscopy

2.8

49.4

254

932

P01AB01

ATC

metronidazole; oral, rectal

1.6

49.3

1776

12966

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

49.1

567

2973

JFB30

NOMESCO Finland

Right hemicolectomy

4.3

47.6

123

290

K92.1

ICD-10 Finland

Melaena

2.4

47.3

348

1522

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

5.4

46.7

176

A02BC05

ATC

esomeprazole; systemic

1.6

46.0

1911

14358

A02BC03

ATC

lansoprazole; oral

1.6

45.7

1394

9730

WX002

NOMESCO Finland

Sedation and analgesia

1.7

45.5

1006

6460

SPAT1104

SPAT

Monitoring of emergency patient

2.3

43.7

372

1731

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

43.5

698

4077

R06.0

ICD-10 Finland

Dyspnoea

1.6

42.5

1396

9884

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

5.4

41.6

154

J01DB01

ATC

cefalexin; oral

1.7

41.4

3682

32551

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

41.0

1109

7477

N02AX02

ATC

tramadol; systemic, rectal

1.5

40.9

2041

15831

H02AB06

ATC

prednisolone; systemic

1.5

40.3

2208

17448

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

40.1

1431

10299

S18

ICPC

Laceration/cut

1.5

40.0

2322

18565

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

5.9

39.9

121

JN4BD

NOMESCO Finland

Extensive body CT

1.9

38.7

582

3323

A07EC02

ATC

mesalazine; oral, rectal

2.5

38.1

261

1103

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

3.2

36.7

149

478

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

36.4

476

2594

UJF92

NOMESCO Finland

Capsular endoscopy

3.3

36.2

136

416

JFB20

NOMESCO Finland

Ileocaecal resection

6.6

36.1

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

35.9

986

6643

D01

ICPC

Abdominal pain/cramps general

1.8

35.8

553

3178

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

35.7

1681

12770

C05AA08

ATC

fluocortolone; rectal, topical

1.8

35.4

662

4029

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

3.7

33.6

109

303

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.2

33.6

301

1426

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

33.4

1708

13141

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

33.3

1185

8453

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.0

33.1

149

508

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

6.2

33.0

C03CA01

ATC

furosemide; systemic

1.5

32.8

1592

12113

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.6

32.7

187

725

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

4.0

32.6

241

R03AC02

ATC

salbutamol; inhalant

1.4

31.8

2310

18949

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

31.3

751

4875

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

2.5

31.2

200

819

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

31.2

880

5941

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

30.3

812

5410

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

3.9

30.1

237

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

30.0

247

1131

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

29.9

390

2119

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

29.8

603

3737

C07AB07

ATC

bisoprolol; oral

1.4

29.5

2423

20216

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

29.4

1681

13125

M54.5

ICD-10 Finland

Low back pain

1.5

29.4

1550

11919

M79.6

ICD-10 Finland

Pain in limb

1.4

29.3

1934

15504

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

3.3

29.3

111

342

UKC02

NOMESCO Finland

Cystoscopy

1.6

29.2

851

5779

SPAT1153

SPAT

Removal of sutures

1.5

29.2

1527

11722

G47.3

ICD-10 Finland

Sleep apnoea

1.5

29.0

1034

7345

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

28.9

502

2979

C180, 8211, 2

ICD-O-3

80.7

28.8

J01AA02

ATC

doxycycline; systemic

1.5

28.7

3441

30720

D06

ICPC

Abdominal pain localized other

1.9

28.6

410

2297

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

28.5

515

3093

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.8

28.4

147

541

K64.1

ICD-10 Finland

Second degree haemorrhoids

3.0

28.3

126

427

K55.2

ICD-10 Finland

Angiodysplasia of colon

5.0

27.9

122

N03AX16

ATC

[U] pregabalin

1.5

27.9

1056

7590

J01MA12

ATC

levofloxacin; systemic

1.6

27.7

891

6179

J01CA04

ATC

amoxicillin; systemic

1.5

27.7

3448

30871

A98

ICPC

Health maint/preventive medicine

2.2

27.6

4310

40846

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.4

27.6

198

854

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

27.2

1124

8219

A02BC04

ATC

rabeprazole; oral

1.9

27.1

394

2216

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

27.0

482

2881

JEA01

NOMESCO Finland

Laparoscopic appendectomy

2.7

27.0

148

562

C180, 8148, 2

ICD-O-3

62.4

26.9

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

26.9

858

5936

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

26.9

1854

14906

B80

ICPC

Iron deficiency anaemia

2.7

26.8

143

535

UJG02

NOMESCO Finland

Proctoscopy

2.8

26.8

132

474

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

26.6

212

958

A06AC51

ATC

ispaghula, combinations; oral

2.1

26.5

246

1182

-, ,

ICD-10 Finland

2.9

26.2

126

446

AA1AD

NOMESCO Finland

CT of head and brain

1.4

26.1

1457

11264

SPAT1263

SPAT

Sampling

1.4

26.0

1784

14302

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

26.0

560

3523

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.2

25.8

236

1127

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

25.4

852

5950

WX402

NOMESCO Finland

General anaesthesia

1.5

25.3

958

6865

D16

ICPC

Rectal bleeding

2.7

25.2

140

535

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

25.0

2998

26337

N06AX11

ATC

mirtazapine; oral

1.4

24.6

1450

11293

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

4.6

24.5

124

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

24.4

609

3972

JAH01

NOMESCO Finland

Laparoscopy

2.3

24.3

193

871

J01MA02

ATC

ciprofloxacin; systemic

1.4

24.2

1763

14230

R06AE07

ATC

cetirizine; oral

1.4

24.2

1733

13949

A02BC01

ATC

omeprazole; systemic

1.4

24.1

1217

9209

R02

ICPC

Shortness of breath/dyspnoea

1.6

24.0

664

4439

K30

ICD-10 Finland

Functional dyspepsia

1.7

24.0

502

3132

XKD00

NOMESCO Finland

Uroflowmetry

1.5

23.9

822

5767

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

23.6

2113

17614

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

23.3

351

1993

D11

ICPC

Diarrhoea

1.7

23.3

453

2771

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

23.2

1733

14014

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

23.2

962

7005

D12

ICD-10 Finland

Benign neoplasm of colon, rectum, anus and anal canal

5.1

23.0

J01FA06

ATC

roxithromycin; oral

1.4

23.0

1657

13314

R19.4

ICD-10 Finland

Change in bowel habit

2.4

22.7

161

691

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

22.5

275

1460

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

22.5

331

1867

B01AB10

ATC

tinzaparin; parenteral

1.6

22.4

533

3432

207

Kela drug reimbursment

Chronic arrhythmias

1.5

22.3

855

6123

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

22.0

758

5312

SPAT1097

SPAT

Recording of ECG

1.5

21.9

707

4885

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.5

21.8

142

587

B01AA03

ATC

warfarin; systemic

1.5

21.6

931

6821

R01AD09

ATC

mometasone; nasal

1.4

21.5

1739

14196

Z2221

NOMESCO Finland

Medical doctor

1.4

21.4

1111

8421

D12

ICPC

Constipation

2.1

21.2

205

1000

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.2

21.2

182

848

B82

ICPC

Anaemia other/unspecified

2.3

21.1

169

766

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

4.7

21.0

103

K51.5

ICD-10 Finland

Left sided colitis

2.6

20.9

118

455

A04

ICPC

Weakness/tiredness general

1.5

20.8

683

4730

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.0

20.8

301

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

4.8

20.8

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

20.7

642

4392

R53

ICD-10 Finland

Malaise and fatigue

1.4

20.7

1046

7882

SPAT1254

SPAT

Administration of medicine

1.5

20.6

652

4479

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

3.2

20.6

256

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

20.4

833

6030

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

20.4

1294

10137

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

20.3

284

1575

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

20.3

714

5017

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

20.3

1166

8982

G04CA02

ATC

tamsulosin; oral

1.4

20.3

1175

9064

R03BB04

ATC

tiotropium bromide; inhalant

1.6

20.1

492

3187

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

20.1

1119

8572

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

20.0

411

2547

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

20.0

239

1259

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

20.0

988

7411

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

19.9

215

1093

B01AF02

ATC

apixaban; oral

1.5

19.6

724

5132

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

19.6

283

1585

H02AB04

ATC

methylprednisolone; systemic

1.5

19.6

619

4249

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

19.6

369

2234

-60

ICPC

Result test/procedure

1.9

19.5

266

1464

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

19.4

343

2039

A07EA06

ATC

budesonide; oral, local oral

2.2

19.4

160

733

SPAT1216

SPAT

Assessment of functional ability

1.5

19.4

748

5351

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

14.6

19.4

L01BC06

ATC

capecitabine; oral

2.0

19.2

204

1031

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.9

19.2

254

1384

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

19.2

400

2488

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

19.1

1230

9638

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

19.1

751

5390

SPAT1301

SPAT

No procedures

1.4

19.0

1363

10865

R42

ICD-10 Finland

Dizziness and giddiness

1.4

18.9

1063

8140

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

18.9

660

4625

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

4.6

18.9

B01AF01

ATC

rivaroxaban; oral

1.5

18.8

655

4588

WVA20

NOMESCO Finland

Medicine administration

2.3

18.8

142

628

L03

ICPC

Low back symptom/complaint

1.4

18.7

1204

9426

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

18.7

1843

15402

S29

ICPC

Skin symptom/complaint other

1.4

18.6

923

6917

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

5.2

18.4

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

18.4

598

4127

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

7.9

18.3

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

17.6

18.2

A01

ICPC

Pain general/multiple sites

1.6

18.2

464

3034

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

18.1

312

1841

L17

ICPC

Foot/toe symptom/complaint

1.4

18.1

1359

10889

D02

ICPC

Abdominal pain epigastric

1.8

18.1

265

1491

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

3.6

18.1

161

J45

ICD-10 Finland

Asthma

1.6

17.8

417

2669

SPAT1255

SPAT

Intravenous administration of medicine

1.7

17.7

316

1884

N03AX12

ATC

[U] gabapentin; oral

1.5

17.6

699

5020

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.1

17.6

169

824

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.2

17.5

148

686

U07

ICPC

Urine symptom/complaint other

1.6

17.5

413

2649

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

17.4

1939

16432

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

17.3

212

1126

J46

ICD-10 Finland

Status asthmaticus

2.3

17.3

135

605

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

17.1

2178

18778

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

17.1

619

4364

T90

ICPC

Diabetes non-insulin dependent

1.4

17.0

1173

9260

A06AD11

ATC

lactulose; oral

1.5

17.0

673

4828

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

17.0

2838

25381

R03BA02

ATC

budesonide; inhalant

1.5

16.9

695

5020

C10AC01

ATC

colestyramine; oral

2.3

16.9

132

592

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

17.4

16.9

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

16.8

389

2482

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

16.8

476

3185

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.6

16.8

100

397

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.1

16.8

164

805

E0000UV, ,

ATC

1.3

16.7

1698

14181

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

16.7

307

1847

D19

ICPC

Teeth/gum symptom/complaint

1.4

16.6

1136

8951

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

16.6

592

4158

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

16.6

1155

9127

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

16.6

877

6630

K62.1

ICD-10 Finland

Rectal polyp

3.2

16.4

197

L04AX01

ATC

azathioprine; systemic

2.0

16.4

173

874

M48.0

ICD-10 Finland

Spinal stenosis

1.5

16.3

611

4334

ZX120

NOMESCO Finland

Intravenous

1.6

16.3

414

2703

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

16.1

537

3720

J02AC01

ATC

fluconazole; systemic

1.3

16.1

1419

11602

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

3.1

16.1

225

A07EA02

ATC

hydrocortisone; rectal

2.6

16.1

370

JFB43

NOMESCO Finland

Left hemicolectomy

4.2

16.0

101

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

15.8

591

4188

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

15.8

910

6969

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

15.8

1577

13113

G04BD12

ATC

mirabegron; oral

1.5

15.7

612

4372

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

15.7

141

670

R4110

NOMESCO Finland

Physiotherapy

1.3

15.6

1202

9627

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.0

15.6

168

854

R96

ICPC

Asthma

1.5

15.6

443

2965

N05CF01

ATC

zopiclone; oral

1.3

15.6

1370

11187

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

15.5

172

884

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

15.5

770

5752

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

15.4

1226

9864

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

15.4

205

1120

K59.0

ICD-10 Finland

Constipation

1.8

15.3

256

1498

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

15.3

313

1935

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

2.9

15.3

237

R03AC03

ATC

terbutaline; inhalant

1.5

15.3

532

3717

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

15.2

1107

8786

G44.2

ICD-10 Finland

Tension-type headache

1.5

15.2

498

3436

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

15.2

331

2081

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

4.4

15.2

H02AB07

ATC

prednisone; oral

1.5

15.1

567

4021

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

15.1

355

2274

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

3.4

15.0

162

R52.9

ICD-10 Finland

Pain, unspecified

1.5

15.0

434

2915

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

15.0

1381

11337

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

14.9

473

3243

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

14.9

2963

26865

Z3231

NOMESCO Finland

Registered nurse

1.3

14.8

1137

9092

-48

ICPC

Clarification/discussion RFE/demand

2.6

14.7

321

SPAT1260

SPAT

Consultation of another employee

1.4

14.7

737

5508

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.4

14.7

100

423

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

4.7

14.7

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

4.6

14.7

K78

ICPC

Atrial fibrillation/flutter

1.6

14.7

401

2660

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

14.6

247

1451

21132

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Caeci

+∞

14.6

JN4CD

NOMESCO Finland

Very extensive body CT

1.9

14.6

181

967

D18

ICPC

Change in faeces/bowel movements

2.1

14.5

128

605

R15

ICD-10 Finland

Faecal incontinence

2.0

14.3

146

728

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.7

14.3

286

1759

N06AX21

ATC

duloxetine; oral

1.5

14.2

458

3147

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

14.2

1105

8843

R03DC03

ATC

montelukast; oral

1.4

14.2

607

4408

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.3

14.2

111

499

M01AH05

ATC

etoricoxib; oral

1.3

14.2

2506

22305

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

14.2

402

2689

R03BA05

ATC

fluticasone; inhalant

1.4

14.1

682

5062

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

14.1

671

4968

A10BA02

ATC

metformin; oral

1.3

14.1

1290

10562

K29.7

ICD-10 Finland

Gastritis, unspecified

2.0

14.1

162

844

L13

ICPC

Hip symptom/complaint

1.4

14.0

889

6899

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

5.4

14.0

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.2

14.0

114

522

C03DA01

ATC

spironolactone; oral

1.4

14.0

573

4130

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

13.9

175

940

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

13.9

950

7458

C10AA05

ATC

atorvastatin; oral

1.3

13.9

2038

17716

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

13.9

1200

9744

M79.1

ICD-10 Finland

Myalgia

1.4

13.8

558

4008

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.2

13.8

109

492

UJF30, ,

SPAT

3.2

13.8

166

JF2BD

NOMESCO Finland

Extensive colon CT

3.3

13.8

156

R35

ICD-10 Finland

Polyuria

1.6

13.7

329

2118

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

13.7

650

4809

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

13.7

1580

13327

U02

ICPC

Urinary frequency/urgency

1.4

13.6

632

4656

Z01.2

ICD-10 Finland

Dental examination

1.3

13.6

1750

14960

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

4.3

13.6

J33.8

ICD-10 Finland

Other polyp of sinus

2.3

13.6

414

WX722

NOMESCO Finland

PEEP

1.8

13.5

203

1152

R01AD58

ATC

fluticasone, combinations; nasal

1.4

13.5

801

6147

SPAT1325

SPAT

Vaccination

1.3

13.5

1459

12196

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

13.5

775

5919

M03BX02

ATC

tizanidine; oral

1.3

13.5

2418

21503

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

3.7

13.4

115

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

13.4

582

4238

ZXD05

NOMESCO Finland

Urgent procedure

1.3

13.3

1156

9382

J01FF01

ATC

clindamycin; systemic

1.3

13.3

1086

8740

K96

ICPC

Haemorrhoids

2.1

13.2

121

580

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

13.2

291

1835

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

13.2

297

1883

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

13.2

758

5789

N02BF01

ATC

gabapentin; oral

1.5

13.1

440

3049

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

13.1

2527

22631

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.2

13.1

105

478

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

13.1

1521

12821

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

4.4

13.1

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

13.0

816

6313

GD1AD

NOMESCO Finland

Thorax CT examination

1.6

13.0

305

1951

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.2

13.0

108

498

K55.8

ICD-10 Finland

Other vascular disorders of intestine

4.1

13.0

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.4

12.9

349

A10BH05

ATC

linagliptin; oral

1.7

12.8

254

1558

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

12.8

1152

9385

-45

ICPC

Observ/health educat/advice/diet

2.0

12.8

130

648

A10AE04

ATC

insulin glargine; parenteral

1.5

12.8

414

2847

R07.3

ICD-10 Finland

Other chest pain

1.5

12.7

443

3091

-34

ICPC

Blood test

2.1

12.7

125

616

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

12.7

184

1034

-50

ICPC

Medication/prescr/renewal

1.8

12.7

177

983

G04CA01

ATC

alfuzosin; oral

1.4

12.7

575

4217

SPAT1312

SPAT

General health counselling

1.3

12.6

1223

10059

R31

ICD-10 Finland

Unspecified haematuria

1.5

12.6

480

3407

SFA10

NOMESCO Finland

One-surface restoration

1.3

12.6

2113

18577

XF404

NOMESCO Finland

Ambulatory ECG

1.5

12.6

391

2664

M54.2

ICD-10 Finland

Cervicalgia

1.6

12.6

310

2008

A03FA02

ATC

cisapride; oral, rectal

1.6

12.6

310

2008

L04

ICPC

Chest symptom/complaint

1.6

12.5

271

1700

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

3.9

12.5

A05

ICPC

Feeling ill

1.8

12.5

189

1076

R13

ICD-10 Finland

Dysphagia

1.6

12.5

320

2092

L05

ICPC

Flank/axilla symptom/complaint

1.6

12.5

277

1750

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

3.7

12.5

107

JFA15, ,

SPAT

3.2

12.4

151

J01DA01

ATC

[U] cefalexin

1.3

12.4

2456

21995

-31

ICPC

Medical examin/health eval partial

1.6

12.4

277

1752

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

12.4

1585

13494

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

12.4

784

6072

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.0

12.4

N30.0

ICD-10 Finland

Acute cystitis

1.4

12.3

680

5154

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

12.3

520

3765

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

12.3

431

3012

J01MA14

ATC

moxifloxacin; systemic

1.5

12.3

374

2540

XJH00

NOMESCO Finland

Transanal ultrasonography

1.6

12.2

284

1815

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

3.4

12.2

123

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.7

12.2

213

1264

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.0

12.2

128

647

WX004

NOMESCO Finland

Patient-controlled sedation

4.0

12.2

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

12.2

254

1580

A10BH01

ATC

sitagliptin; oral

1.5

12.1

441

3104

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

12.1

440

3096

R51.80

ICD-10 Finland

Headache

1.4

12.1

540

3947

8263/2-C18.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of colon, NOS

12.4

12.1

S82

ICPC

Naevus/mole

1.4

12.1

570

4207

R50.9

ICD-10 Finland

Fever, unspecified

1.4

12.0

599

4461

SDA03

NOMESCO Finland

Periodontal treatment

1.3

12.0

1508

12795

K64.2

ICD-10 Finland

Third degree haemorrhoids

2.5

12.0

306

M04AA01

ATC

allopurinol; systemic

1.4

12.0

611

4570

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

11.9

264

1668

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

11.8

179

1019

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.8

11.8

161

888

D64.8

ICD-10 Finland

Other specified anaemias

2.2

11.8

434

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

11.8

233

1430

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

11.7

939

7521

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

11.7

669

5097

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

11.7

848

6696

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

11.7

1186

9798

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

11.7

1411

11910

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

4.9

11.7

R78

ICPC

Acute bronchitis/bronchiolitis

2.2

11.6

423

C189, 8211, 2

ICD-O-3

16.4

11.6

A03

ICPC

Fever

1.4

11.6

540

3973

-35

ICPC

Urine test

2.9

11.6

184

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.7

11.6

189

1100

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.4

11.6

342

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

11.6

248

1553

M01AE02

ATC

naproxen; oral, rectal

1.2

11.6

2161

19165

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

11.6

427

3014

J20

ICD-10 Finland

Acute bronchitis

1.5

11.5

390

2707

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.8

11.5

177

1014

R03BA08

ATC

ciclesonide; inhalant

1.5

11.4

331

2223

TKE00

NOMESCO Finland

Needle biopsy of prostate

1.8

11.4

180

1038

TK800

NOMESCO Finland

Hemodialysis

2.2

11.4

453

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.5

11.4

266

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

11.4

384

2663

A11

ICPC

Chest pain NOS

1.5

11.3

390

2715

K62.3

ICD-10 Finland

Rectal prolapse

2.6

11.3

249

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

11.3

703

5425

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.8

11.3

168

953

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

11.3

1092

8963

B01AB04

ATC

dalteparin; parenteral

1.7

11.2

216

1316

UJF34

NOMESCO Finland

Left colonoscopy

3.3

11.2

125

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

11.2

1465

12472

JG1BG

NOMESCO Finland

MRI of rectum

3.1

11.1

151

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

11.1

195

1159

J01FA10

ATC

azithromycin; systemic

1.2

11.1

2072

18341

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.9

11.1

127

662

L08

ICPC

Shoulder symptom/complaint

1.3

11.1

968

7836

A07AA09

ATC

vancomycin; oral

2.4

11.0

300

F29

ICPC

Eye symptom/complaint other

1.5

11.0

415

2940

WX290

NOMESCO Finland

Other blockage of nerve

1.2

11.0

1601

13785

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

11.0

247

1565

I84

ICD-10 Finland

Hemorrhoids

2.0

11.0

117

595

M10.9

ICD-10 Finland

Gout, unspecified

1.5

10.9

328

2219

ZXA00

NOMESCO Finland

Right side

1.3

10.9

1119

9243

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

10.9

268

1735

M25.5

ICD-10 Finland

Pain in joint

1.3

10.9

1250

10469

X58

ICD-10 Finland

Exposure to other specified factors

1.4

10.9

519

3837

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

10.8

199

1198

I84.5

ICD-10 Finland

External hemorrhoids without complication

1.9

10.8

125

654

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

10.8

570

4284

-62

ICPC

Administrative procedure

2.0

10.8

115

585

D82

ICPC

Teeth/gum disease

1.3

10.8

1300

10949

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.5

10.8

401

2834

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.1

10.8

457

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

10.8

317

2137

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

10.8

331

2252

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

10.7

1708

14842

L86

ICPC

Back syndrome with radiating pain

1.6

10.7

254

1630

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.4

10.7

298

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

10.7

556

4166

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

10.7

1751

15258

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

2.8

10.7

187

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

10.7

469

3415

C01DA14

ATC

isosorbide mononitrate; oral

1.3

10.7

713

5556

UJF32, ,

SPAT

1.8

10.7

153

858

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

2.9

10.6

166

R74

ICPC

Upper respiratory infection acute

1.3

10.6

975

7937

SPAT1310

SPAT

Counselling related to known health issue

1.3

10.6

1264

10626

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.6

10.6

239

1517

K29.8

ICD-10 Finland

Duodenitis

3.0

10.5

151

C10AA01

ATC

simvastatin; oral

1.2

10.5

1989

17596

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.5

10.5

292

1944

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

10.5

129

689

R5110, ,

SPAT

1.4

10.5

405

2882

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

10.4

293

1955

I50

ICD-10 Finland

Heart failure

1.8

10.4

141

777

SFA30

NOMESCO Finland

Three-surface restoration

1.2

10.4

1651

14331

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

10.4

896

7234

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

10.4

1042

8577

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

10.4

525

3918

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

2.9

10.3

158

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

10.3

137

751

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

10.3

489

3611

EMAK, ,

NOMESCO Finland

1.9

10.3

135

737

R21

ICPC

Throat symptom/complaint

1.4

10.2

594

4530

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

10.2

247

1593

G04CB01

ATC

finasteride; oral

1.4

10.2

508

3779

A04.8

ICD-10 Finland

Other specified bacterial intestinal infections

2.3

10.2

330

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

10.2

380

2688

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

10.1

781

6207

SPAT1262

SPAT

Handing over of treatment supplies

1.3

10.1

749

5919

A10BK01

ATC

dapagliflozin; oral

1.5

10.1

348

2421

JF1AD

NOMESCO Finland

Small bowel CT

3.0

10.1

144

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

10.1

162

940

JG1JG

NOMESCO Finland

MRI of rectal function (MR defecography)

4.2

10.1

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

10.1

277

1840

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

10.0

975

7988

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

3.5

10.0

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

10.0

403

2890

Z53.0

ICD-10 Finland

Procedure not carried out because of contraindication

4.8

10.0

U71

ICPC

Cystitis/urinary infection other

1.5

10.0

270

1787

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.8

10.0

134

737

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

10.0

1187

9966

R04

ICPC

Breathing problem other

1.7

9.9

161

937

N01

ICPC

Headache

1.5

9.9

321

2207

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

9.9

237

1525

J01DA06

ATC

[U] cefuroxime

1.4

9.9

515

3859

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

9.9

3708

35203

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.6

9.9

200

1235

A10AB05

ATC

insulin aspart; parenteral

1.5

9.9

306

2086

UJD02

NOMESCO Finland

Gastroscopy

1.6

9.8

201

1245

M01AX17

ATC

nimesulide; oral

1.3

9.8

1001

8247

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.5

9.8

249

WX892

NOMESCO Finland

Monitored bed care

1.5

9.8

319

2198

Z31.5

ICD-10 Finland

Genetic counselling

1.7

9.8

157

912

XF402

NOMESCO Finland

ECG with work load test

1.4

9.7

466

3444

C09CA06

ATC

candesartan; oral

1.3

9.7

975

8014

R60.0

ICD-10 Finland

Localized oedema

1.4

9.7

562

4282

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.7

9.7

179

1079

C01AA05

ATC

digoxin; systemic

1.5

9.7

333

2317

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

9.7

1007

8315

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

9.7

283

1906

Z3226

NOMESCO Finland

Physiotherapist

1.3

9.6

716

5660

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

9.6

1112

9297

JF1BD

NOMESCO Finland

Very extensive small bowel CT

3.4

9.6

R01AD08

ATC

fluticasone; nasal

1.3

9.6

1002

8279

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

9.6

457

3377

S97

ICPC

Chronic ulcer skin

1.5

9.6

291

1976

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

9.5

1117

9352

-42

ICPC

Electrical tracing

2.3

9.5

296

L14

ICPC

Leg/thigh symptom/complaint

1.5

9.5

335

2343

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.0

9.5

104

535

C08CA01

ATC

amlodipine; oral

1.2

9.5

1804

15911

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.2

9.5

367

D04

ICPC

Rectal/anal pain

2.4

9.5

278

E000001, ,

ATC

1.3

9.5

687

5412

SPAT1210

SPAT

Application of cast or individual aid

1.7

9.5

159

935

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

3.0

9.4

139

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

9.4

339

2381

L29.9

ICD-10 Finland

Pruritus, unspecified

1.9

9.4

112

593

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

9.4

833

6741

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

9.4

388

2796

JFA97

NOMESCO Finland

Other laparoscopic local operation on intestine

+∞

9.4

N05CF02

ATC

zolpidem; oral

1.3

9.4

629

4900

D37.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Appendix

5.2

9.3

H25.8

ICD-10 Finland

Other senile cataract

1.4

9.3

534

4061

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

9.3

1025

8514

L01

ICPC

Neck symptom/complaint

1.3

9.3

597

4618

A10BK03

ATC

empagliflozin; oral

1.4

9.3

461

3429

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.8

9.3

131

733

L15

ICPC

Knee symptom/complaint

1.3

9.2

1029

8561

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.5

9.2

249

1649

R01AD05

ATC

budesonide; nasal

1.5

9.2

266

1788

K61.0

ICD-10 Finland

Anal abscess

2.5

9.2

221

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

9.2

474

3548

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

9.2

117

634

R03AC12

ATC

salmeterol; inhalant

1.7

9.2

175

1066

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.5

9.2

283

1928

K60.3

ICD-10 Finland

Anal fistula

2.4

9.1

270

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

9.1

634

4961

J05AB11

ATC

valaciclovir; oral

1.3

9.1

561

4313

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.8

9.1

144

833

JEA00

NOMESCO Finland

Appendectomy

1.6

9.1

196

1231

C07AA05

ATC

propranolol; systemic

1.3

9.1

673

5317

K60.1

ICD-10 Finland

Chronic anal fissure

2.0

9.1

434

A06AX04

ATC

linaclotide; oral

4.0

9.0

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

3.0

9.0

132

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

2.8

9.0

154

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

1.9

9.0

108

574

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

9.0

829

6740

G04BD08

ATC

solifenacin; oral

1.5

8.9

293

2020

R03BC03

ATC

nedocromil; inhalant

1.5

8.9

252

1684

N05BA04

ATC

oxazepam; oral

1.3

8.9

999

8312

A97

ICPC

No disease

1.3

8.9

812

6589

JFA84

NOMESCO Finland

Laparoscopic excision of lesion of colon

24.0

8.9

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.5

8.9

316

2214

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.6

8.9

195

JFB50

NOMESCO Finland

Other resection of colon

4.3

8.9

JHB00

NOMESCO Finland

Hemorrhoidectomy

1.8

8.9

127

714

D50

ICD-10 Finland

Iron deficiency anaemia

2.1

8.8

371

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.7

8.8

141

818

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

1.9

8.8

115

628

R05

ICD-10 Finland

Cough

1.3

8.8

855

6993

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

8.8

351

2514

A99

ICPC

Disease/condition unspecnature/site

1.4

8.8

428

3173

L72.1

ICD-10 Finland

Trichilemmal cyst

1.5

8.8

264

1789

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

8.8

447

3339

K04

ICPC

Palpitations/awareness of heart

1.6

8.8

208

1338

SPAT1240

SPAT

Therapeutic discussion

1.5

8.7

279

1914

N06AX26

ATC

vortioxetine; oral

1.6

8.7

218

1419

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.3

8.7

289

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

8.7

752

6063

L12

ICPC

Hand/finger symptom/complaint

1.3

8.7

641

5060

I84.4

ICD-10 Finland

External hemorrhoids with other complications

2.6

8.6

186

N06AB10

ATC

escitalopram; oral

1.3

8.6

622

4892

A07AA02

ATC

nystatin; oral

1.5

8.6

240

1600

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.6

8.6

202

1296

D13.3

ICD-10 Finland

Benign neoplasm: Other and unspecified parts of small intestine

3.7

8.6

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

4.6

8.6

ZXE10

NOMESCO Finland

More than one and less than three hours

1.2

8.6

1442

12528

K02.1

ICD-10 Finland

Caries of dentine

1.2

8.6

2156

19474

F01

ICPC

Eye pain

1.9

8.6

103

548

C08CA13

ATC

lercanidipine; oral

1.3

8.6

655

5194

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

1.9

8.5

499

TJF80

NOMESCO Finland

Ostomy education

2.5

8.5

217

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

3.1

8.5

110

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

8.5

2562

23529

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

8.5

386

2828

R03BA01

ATC

beclometasone; inhalant

1.3

8.5

521

4006

D99

ICPC

Disease digestive system other

2.5

8.5

194

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.1

8.4

365

C180, 8213, 2

ICD-O-3

90.2

8.4

WZC30

NOMESCO Finland

Teaching

1.3

8.4

698

5594

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

1.7

8.4

146

868

SPAT1167

SPAT

Insertion of urinary catheter

1.7

8.4

142

839

J01MA06

ATC

norfloxacin; oral

1.4

8.4

481

3661

Z71.8

ICD-10 Finland

Other specified counselling

1.2

8.3

1265

10869

I20.09

ICD-10 Finland

Unstable angina

1.5

8.3

249

1686

N28.1

ICD-10 Finland

Cyst of kidney

2.1

8.3

334

JG1CG

NOMESCO Finland

Extensive MRI of rectum

3.0

8.3

117

R05

ICPC

Cough

1.3

8.3

963

8038

M01AB05

ATC

diclofenac; systemic, rectal

1.2

8.3

2635

24293

S10

ICPC

Boil/carbuncle

1.5

8.3

226

1501

R19.5

ICD-10 Finland

Other faecal abnormalities

2.1

8.3

381

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.6

8.2

167

1034

R39.1

ICD-10 Finland

Other difficulties with micturition

1.7

8.2

137

805

K29.1

ICD-10 Finland

Other acute gastritis

2.4

8.2

227

K64.3

ICD-10 Finland

Fourth degree haemorrhoids

2.9

8.2

123

UJF02

NOMESCO Finland

Peroral enteroscopy

3.2

8.2

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

6.5

8.2

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

8.1

123

703

A46

ICD-10 Finland

Erysipelas

1.3

8.1

628

4984

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.6

8.1

190

1218

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

8.1

574

4503

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

1.8

8.1

106

581

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.5

8.0

221

1470

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.3

8.0

601

4749

L29

ICPC

Musculoskeletal sympt/complt other

1.4

8.0

356

2597

N06AA09

ATC

amitriptyline; systemic

1.4

8.0

383

2829

XCD10

NOMESCO Finland

Electrophysiological examination of eye

1.9

8.0

496

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

8.0

950

7943

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

8.0

489

3754

L57.0

ICD-10 Finland

Actinic keratosis

1.3

8.0

508

3922

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

3.1

8.0

104

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.7

7.9

159

D25

ICPC

Abdominal distension

2.0

7.9

394

K58

ICD-10 Finland

Irritable bowel syndrome

2.0

7.9

415

I50.0

ICD-10 Finland

Congestive heart failure

1.4

7.9

319

2290

M02AA07

ATC

piroxicam; topical

1.2

7.9

1473

12909

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

2.7

7.8

143

S21

ICPC

Skin texture symptom/complaint

1.3

7.8

639

5107

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

1.8

7.8

104

572

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

7.8

311

2226

WF001

NOMESCO Finland

Preoperative radiotherapy

2.5

7.8

178

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

7.8

1111

9473

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.5

7.8

211

1399

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

7.8

339

2467

A10BJ06

ATC

semaglutide; parenteral

1.6

7.8

197

1288

A10BJ02

ATC

liraglutide; parenteral

1.8

7.7

108

603

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

7.7

1054

8943

D01AC02

ATC

miconazole; topical

1.4

7.7

287

2028

C01BC04

ATC

flecainide; systemic

1.7

7.7

150

919

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

7.7

639

5116

R11

ICD-10 Finland

Nausea and vomiting

1.4

7.7

315

2266

R12

ICD-10 Finland

Heartburn

1.4

7.7

302

2157

K80

ICPC

Cardiac arrhythmia NOS

1.4

7.7

359

2643

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

7.7

301

2149

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

4.3

7.7

M01AC06

ATC

meloxicam; systemic, rectal

1.2

7.7

1436

12580

A08

ICPC

Swelling

1.5

7.6

258

1791

A03CA02

ATC

clidinium and psycholeptics; oral

1.5

7.6

228

1544

R03AK11

ATC

formoterol and fluticasone; inhalant

1.9

7.6

519

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.6

7.6

159

992

A29

ICPC

General symptom/complaint other

1.3

7.6

560

4413

A02BA02

ATC

ranitidine; systemic

1.3

7.6

768

6300

F05

ICPC

Visual disturbance other

1.7

7.6

126

740

J01FA09

ATC

clarithromycin; systemic

1.2

7.6

1100

9391

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

4.0

7.6

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

2.4

7.6

217

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

2.5

7.6

187

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.5

7.6

209

1393

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

7.5

319

2309

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.4

7.5

306

2199

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

7.5

181

1169

8480/1-C18.1

ICD-O-3

Low grade appendiceal mucinous neoplasm of appendix

10.0

7.5

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

7.5

275

1939

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.2

7.5

295

WX320

NOMESCO Finland

Spinalanesthesy

1.2

7.5

1030

8746

D75

ICPC

Malignant neoplasm colon/rectum

2.5

7.5

176

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.3

7.5

231

SAA04

NOMESCO Finland

Special examination of mouth

1.6

7.5

172

1100

H92.0

ICD-10 Finland

Otalgia

1.5

7.5

197

1300

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.6

7.5

186

1212

K59.01

ICD-10 Finland

Constipation outlet obstruction type

2.3

7.4

219

C09CA01

ATC

losartan; oral

1.2

7.4

1141

9798

K92.0

ICD-10 Finland

Haematemesis

1.9

7.4

517

-61

ICPC

Result examination/test/record/letter from other provider

3.5

7.4

SPAT1229

SPAT

Assessment of need for aid

1.4

7.4

316

2291

K57

ICD-10 Finland

Diverticular disease of intestine

1.9

7.4

503

SPAT1281

SPAT

Other administrative function

1.4

7.4

283

2013

A11CC03

ATC

alfacalcidol; systemic

1.8

7.4

547

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

1.9

7.4

433

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

7.4

1619

14380

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.7

7.4

140

854

B02AA02

ATC

tranexamic acid; systemic

1.3

7.4

454

3491

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.4

7.4

270

1905

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

7.3

136

824

JFB46

NOMESCO Finland

Resection of sigmoid colon

2.3

7.3

233

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.7

7.3

141

863

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

7.3

294

2109

I45.9

ICD-10 Finland

Conduction disorder, unspecified

2.5

7.3

178

E66.8

ICD-10 Finland

Other obesity

1.6

7.3

161

1019

JFB00

NOMESCO Finland

Partial resection of small intestine

2.0

7.3

345

K573, D120,

ICD-10 Finland

+∞

7.3

R55

ICD-10 Finland

Syncope and collapse

1.3

7.3

458

3533

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

7.3

261

1835

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

7.2

465

3597

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

7.2

404

3061

N06AX16

ATC

venlafaxine; oral

1.3

7.2

442

3395

U05

ICPC

Urination problems other

1.5

7.2

237

1637

J01EA01

ATC

trimethoprim; systemic

1.2

7.2

957

8091

R5140

NOMESCO Finland

Monitoring the use of the aid

1.3

7.2

431

3299

M01AH01

ATC

celecoxib; oral

1.3

7.2

707

5780

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022145) Colonoscopy Study observation

2145

4923

7.39

307.65

1.6

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1252

5279

2.90

201.97

4.7

4.3

4.88

23.58

ug/l

5.96

1079

4354

(3048689) Calprotectin [Mass/mass] in Stool

1088

4718

2.72

162.03

2.4

2.2

150.47

148.59

ug/g

0.06

888

3733

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2017

12144

2.19

139.43

3.1

2.4

3.19

2.86

mg/l

6.83

1823

10451

(3024561) Albumin [Mass/volume] in Serum or Plasma

2949

20790

2.20

133.82

6.5

5.3

35.35

35.07

g/l

2.12

2845

19407

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3206

23558

2.24

128.34

8.0

7.0

11.22

11.94

umol/l

3.50

3093

22492

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2671

18469

2.09

122.67

4.1

3.1

127.25

147.39

ug/l

3.39

2515

16991

(40768797) Stomach Pathology biopsy report

1211

6228

2.29

120.01

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

2191

14356

2.02

113.53

3.1

2.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3984

32850

2.79

112.42

11.5

8.9

79.22

81.06

u/l

1.38

3860

31131

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2166

14174

2.01

112.22

3.2

2.7

61.74

66.26

u/l

0.32

2040

13090

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1766

11021

1.99

102.03

2.9

2.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2769

20146

1.97

101.32

3.4

2.9

—

estimate

—

(40768804) Tissue Pathology biopsy report

2432

17123

1.91

96.08

2.6

2.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

3158

24349

1.99

93.66

11.0

9.9

4.19

4.20

e9/l

0.17

2792

20974

(3022948) Iron [Moles/volume] in Serum or Plasma

1386

8146

2.01

93.26

3.3

2.7

11.95

12.45

umol/l

1.61

1310

7579

(3007164) IgA [Mass/volume] in Serum or Plasma

1313

7614

2.02

91.44

1.6

1.5

2.58

2.59

g/l

0.04

792

4487

(3006315) Basophils [#/volume] in Blood

2888

21734

1.91

90.49

7.7

6.3

0.04

e9/l

0.90

2543

18372

(3031040) Bacteria [#/volume] in Urine by Automated count

3493

28047

2.08

90.47

6.4

5.2

1472.21

1781.06

e6/l

0.08

423

(3013115) Eosinophils [#/volume] in Blood

2945

22360

1.91

89.11

7.9

6.5

0.19

e9/l

0.07

2610

19216

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3739

30869

2.22

89.04

6.2

4.6

14.35

13.58

mm/h

2.22

3536

28671

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1429

8601

1.97

89.01

1.4

1.3

1.76

1.70

u/ml

0.04

347

2194

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1314

7687

2.00

88.82

3.2

2.7

2.38

2.27

g/l

9.77

1234

7093

(3019198) Lymphocytes [#/volume] in Blood

2910

22053

1.90

88.02

7.7

6.4

1.91

1.87

e9/l

0.24

2604

19100

(3001604) Monocytes [#/volume] in Blood

2869

21651

1.89

87.84

7.7

6.3

0.60

0.61

e9/l

1.83

2529

18290

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1226

7134

1.99

83.26

3.3

2.8

20.43

22.10

4.10

1159

6620

(3015736) pH of Urine

2433

17804

1.79

78.31

4.9

3.7

6.35

6.26

3.65

1316

9674

(3013826) Glucose [Moles/volume] in Serum or Plasma

3272

26260

1.89

76.81

6.9

5.3

6.89

6.80

mmol/l

1.33

3166

25091

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2730

20763

1.80

76.12

2.6

2.2

96.45

95.10

pmol/l

0.75

1605

10804

(3032080) INR in Blood by Coagulation assay

2852

22005

1.80

75.39

22.9

17.4

1.34

1.30

inr

3.51

2420

18493

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2757

21199

1.77

72.24

8.9

6.9

1.20

1.21

mmol/l

3.05

2610

19517

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

542

2419

2.41

71.32

2.7

2.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

3475

28710

1.91

71.02

6.2

5.0

—

2.37

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4311

38892

3.35

69.39

27.0

18.8

26.65

26.07

mg/l

0.57

3878

32712

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

2234

16501

1.70

64.62

4.4

3.6

—

1.41

—

(3035350) Ketones [Presence] in Urine by Test strip

2855

22538

1.72

64.39

5.4

4.2

6.69

3.68

estimate

0.27

456

4948

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2109

15425

1.69

62.60

3.8

3.3

1715.67

1456.22

ng/l

1.17

1867

13526

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2948

23596

1.72

61.97

10.0

7.7

1.21

mmol/l

3.34

2677

20330

(3009261) Glucose [Presence] in Urine by Test strip

2854

22703

1.70

60.77

5.5

4.2

0.03

0.29

estimate

0.61

423

4607

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2325

17541

1.67

60.54

5.3

4.2

52.04

80.65

ng/l

0.55

1843

13474

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3096

25212

1.72

60.05

4.5

3.4

59.23

54.46

u/l

1.61

2935

23272

(3027945) Reticulocytes/Erythrocytes in Blood

994

5967

1.85

58.41

2.6

2.5

1.80

1.81

0.01

896

5303

(3011397) Hemoglobin [Presence] in Urine by Test strip

1555

10633

1.70

58.24

5.4

4.0

0.37

0.12

0.47

128

(3021601) Nitrite [Presence] in Urine by Test strip

2797

22284

1.67

57.68

5.4

4.2

0.00

estimate

0.38

444

4796

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

673

3563

2.04

57.31

1.8

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

1615

11282

1.67

55.05

5.5

4.3

86.56

86.81

0.14

1584

11052

(3000570) Elastase.pancreatic [Mass/mass] in Stool

351

1449

2.54

54.18

1.5

258.75

267.22

ug/g

0.34

216

877

(3023520) Reticulocytes [#/volume] in Blood

812

4724

1.88

52.02

2.7

2.6

68.30

69.05

e9/l

0.27

628

3459

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

798

4642

1.87

51.06

2.6

2.2

0.21

0.20

g/l

3.52

759

4327

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4060

36508

2.10

49.84

6.6

5.6

1.97

2.00

mu/l

0.56

3813

33316

(3021960) Folate [Moles/volume] in Serum or Plasma

1888

13987

1.60

49.27

1.9

1.7

19.97

20.30

nmol/l

0.41

1659

11690

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1235

8241

1.69

48.94

3.6

3.2

1.00

1.14

e6/l

0.59

774

4477

(3018095) Leukocytes [#/volume] in Urine

2179

16735

1.58

48.51

5.1

4.2

90.95

110.57

e6/l

0.34

1609

12035

(36660697) Celiac disease serology panel - Serum

574

3066

2.00

47.10

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4359

40566

3.09

46.93

32.4

22.8

139.68

139.67

mmol/l

0.08

4310

39834

(3023368) Bacteria identified in Blood by Culture

1821

13502

1.58

46.56

4.9

4.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3538

30676

1.71

46.18

5.2

4.5

15.10

14.99

pmol/l

1.68

3277

27789

(3023103) Potassium [Moles/volume] in Serum or Plasma

4359

40617

3.05

45.82

32.6

23.0

3.99

mmol/l

0.26

4308

39825

(3003327) Ova and parasites identified in Stool by Light microscopy

297

1244

2.49

44.29

1.9

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1229

8373

1.64

44.13

1.9

1.8

1133.43

1167.77

nmol/l

0.60

961

6268

(3019069) Monocytes/Leukocytes in Blood

2495

20044

1.55

43.57

8.1

6.7

9.18

9.09

0.80

2357

18669

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1928

14637

1.55

43.52

2.6

2.2

206.66

210.63

u/l

0.06

1838

13777

(3018010) Neutrophils/Leukocytes in Blood

2480

19910

1.54

43.34

7.7

6.5

58.29

58.01

0.54

2374

18936

(3015377) Calcium [Moles/volume] in Serum or Plasma

2073

16008

1.54

43.23

3.9

3.7

2.35

2.36

mmol/l

0.51

1902

14423

(3006504) Eosinophils/Leukocytes in Blood

2487

19994

1.54

43.07

8.0

6.6

2.83

2.85

0.18

2356

18622

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4144

37917

2.12

42.71

24.6

18.8

74.11

75.45

ml/min/173m2

4.30

3983

35483

(3016502) Oxygen saturation in Arterial blood

856

5353

1.74

42.20

8.7

7.8

95.99

95.45

2.42

842

5172

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4362

40850

2.94

41.72

18.0

13.5

24.93

25.56

u/l

1.51

4294

39502

(3026493) Urate [Moles/volume] in Serum or Plasma

1606

11792

1.56

41.54

3.4

2.9

360.49

351.31

umol/l

2.82

1421

10218

(3003396) Base excess in Arterial blood by calculation

925

5932

1.70

41.54

8.4

7.5

0.69

0.99

mmol/l

1.48

784

4880

(3022096) Basophils/Leukocytes in Blood

2478

20000

1.53

41.43

8.1

6.7

0.70

0.67

1.85

2354

18619

(3002582) Erythrocytes [#/volume] in Urine

1968

15122

1.53

41.36

4.2

3.6

75.23

73.10

e6/l

0.02

1571

11649

(3019977) pH of Arterial blood

928

5970

1.70

41.14

8.4

7.6

7.42

0.11

506

3301

(3002030) Lymphocytes/Leukocytes in Blood

2507

20318

1.53

40.85

8.0

6.6

26.39

26.65

0.57

2395

19139

(3014111) Lactate [Moles/volume] in Serum or Plasma

738

4465

1.78

40.69

8.8

7.6

1.35

1.33

mmol/l

0.15

724

4388

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

917

5906

1.69

40.40

4.2

4.4

228.59

246.18

u/l

4.48

872

5594

(3027801) Oxygen [Partial pressure] in Arterial blood

925

5981

1.69

40.12

8.5

7.6

12.18

kpa

0.01

899

5761

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

925

5982

1.69

40.09

8.5

7.6

5.06

5.09

kpa

0.55

902

5763

(3019150) Specific gravity of Urine by Refractometry

1382

9879

1.57

39.84

6.1

4.5

1.02

1.17

kg/l

0.50

972

6729

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1311

9265

1.58

39.67

2.2

1.7

1.40

1.45

mg/l

0.20

1049

7289

(3030467) Casts [#/volume] in Urine by Automated count

1739

13103

1.53

39.46

4.1

3.5

0.36

0.45

e6/l

1.39

1344

9737

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

849

5405

1.70

38.89

10.6

7.4

—

(3013512) EKG study

2076

16312

1.50

38.20

4.7

4.0

0.86

0.70

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4112

37775

1.98

37.91

8.9

7.2

40.70

40.03

mmol/mol

5.03

3912

34949

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4381

41304

2.97

37.83

35.5

25.2

86.02

80.96

umol/l

9.13

4348

40815

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4159

38378

2.05

37.54

6.8

5.8

6.12

6.05

mmol/l

3.28

3901

34814

(3013139) Helicobacter pylori Ag [Presence] in Stool

520

2894

1.90

37.35

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

787

4957

1.71

37.34

9.3

8.4

117.96

120.24

g/l

2.65

778

4842

(3029937) Albumin [Presence] in Urine by Test strip

1683

12720

1.51

36.97

5.7

4.4

0.01

0.00

estimate

0.28

387

4378

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

811

5167

1.69

36.84

3.0

2.8

7.39

9.00

umol/l

1.80

725

4558

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

462

2484

1.96

36.77

1.6

1.7

1.59

1.56

g/l

0.33

416

2146

(3037522) Nuclear Ab [Titer] in Serum

857

5565

1.67

36.14

1.4

1.3

579.80

507.49

titre

0.50

200

1244

(3045414) Leukocytes [Presence] in Urine

723

4487

1.73

36.09

2.4

2.2

0.00

0.01

estimate

0.78

106

883

(3007461) Platelets [#/volume] in Blood

4397

41627

3.07

35.88

41.9

28.6

244.13

244.82

e9/l

0.28

4341

40728

(3024731) MCV [Entitic mean volume] in Red Blood Cells

4397

41628

3.07

35.86

41.7

28.5

91.80

91.68

1.03

4373

41136

(3026361) Erythrocytes [#/volume] in Blood

4397

41630

3.07

35.82

41.9

28.5

4.36

4.42

e12/l

12.76

4335

40558

(3000963) Hemoglobin [Mass/volume] in Blood

4397

41636

3.06

35.69

42.2

28.8

131.05

133.63

g/l

24.28

4374

41156

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

697

4297

1.74

35.59

3.0

2.5

66.31

40.11

u/l

0.43

614

3626

(3035941) MCH [Entitic mass]

4396

41628

3.04

35.55

41.7

28.5

30.39

30.44

1.16

4372

41137

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

4396

41631

3.04

35.49

42.9

29.1

39.28

39.93

11.81

4370

41122

(3010813) Leukocytes [#/volume] in Blood

4396

41634

3.04

35.43

41.9

28.6

6.89

6.81

e9/l

1.11

4333

40560

(3026008) Bacteria identified in Urine by Culture

1848

14340

1.49

35.20

3.9

3.5

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

616

3678

1.78

35.14

2.9

2.8

59.64

62.49

ml/min/173m2

1.17

275

1614

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1323

9587

1.54

34.93

3.4

3.2

2.46

mmol/l

0.56

1206

8598

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4217

39254

2.11

34.86

7.2

6.4

2.49

2.60

mmol/l

11.95

3978

36038

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2388

19524

1.47

34.73

2.8

2.5

80.59

79.36

nmol/l

1.33

2153

17359

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4005

36674

1.81

34.54

5.3

4.6

1.33

1.29

mmol/l

3.45

3706

33109

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1173

8300

1.56

34.40

2.2

2.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

567

3334

1.80

34.00

2.8

2.9

10.83

10.57

g/l

0.59

531

3074

(3028026) IgM [Mass/volume] in Serum or Plasma

472

2648

1.87

32.89

1.8

2.0

1.44

1.36

g/l

0.23

444

2419

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4127

38256

1.91

32.61

6.1

5.5

1.46

mmol/l

0.40

3874

34963

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4148

38526

1.93

32.40

6.3

5.6

4.43

4.52

mmol/l

7.12

3917

35504

(3003458) Phosphate [Moles/volume] in Serum or Plasma

947

6459

1.59

32.30

7.2

6.1

1.06

1.04

mmol/l

2.13

887

6008

(3000991) Gas panel - Venous blood

679

4263

1.70

32.20

10.6

8.9

—

(3024354) Oxygen [Partial pressure] in Venous blood

663

4157

1.70

31.55

4.0

3.1

4.42

4.49

kpa

0.44

650

4047

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1066

7514

1.55

31.34

3.9

3.3

2.19

2.27

e6/l

0.11

600

3737

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

285

1365

2.16

30.97

1.4

1.3

—

(40758558) Short blood count panel - Blood

1688

13100

1.46

30.95

7.3

6.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2452

20427

1.44

30.54

2.8

2.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

456

2589

1.85

30.51

3.5

2.7

0.64

0.62

0.99

456

2576

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

608

3783

1.70

29.64

4.6

3.9

98.37

94.76

ng/l

0.41

529

3205

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

673

4307

1.66

29.48

1.6

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

760

5016

1.62

29.44

4.7

3.7

5.80

5.81

kpa

0.14

749

4896

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

910

6275

1.56

29.24

2.0

1.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

304

1528

2.06

29.09

1.4

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

335

1744

1.99

29.08

2.9

0.34

iu/ml

0.18

198

971

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2039

16527

1.43

28.93

5.5

4.2

1.48

0.32

estimate

0.37

344

3939

(3020630) Protein [Mass/volume] in Serum or Plasma

694

4503

1.64

28.74

2.9

2.7

65.85

66.08

g/l

0.33

649

4112

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

514

3081

1.75

28.61

10.4

9.4

24.15

24.27

mmol/l

0.38

500

3027

(3042936) Bacteria identified in Isolate by Culture

943

6584

1.55

28.58

2.1

—

(3002032) Base excess in Venous blood by calculation

740

4885

1.62

28.56

4.8

3.7

1.60

1.83

mmol/l

0.98

669

4289

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

558

3445

1.71

27.90

1.6

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

660

4260

1.64

27.84

2.8

2.4

5.94

7.25

ug/l

1.58

586

3749

(3012544) pH of Venous blood

762

5095

1.60

27.82

4.7

3.7

7.38

0.27

450

2946

(3000850) Epithelial cells [#/volume] in Urine

1401

10666

1.45

27.63

3.1

2.8

4.21

5.10

e6/l

2.76

1275

9736

(36304419) Bacteria [Presence] in Urine

1579

12320

1.43

27.17

4.0

3.4

0.00

276.16

estimate

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

350

1895

1.92

27.06

3.7

3.5

586.72

2987.36

u/ml

0.94

312

1631

(3014765) Yersinia sp identified in Stool by Organism specific culture

230

1073

2.20

26.67

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

329

1753

1.95

26.67

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

319

1685

1.96

26.52

5.2

4.0

24.68

24.89

mmol/l

0.60

299

1535

(42529406) Shigella sp [Presence] in Stool by Culture

230

1079

2.19

26.31

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

104

330

3.20

26.18

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

227

1062

2.20

26.14

1.4

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

512

3151

1.70

25.80

1.9

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

238

1147

2.13

25.43

1.2

105.26

104.40

titre

0.01

(3020779) Urea [Moles/volume] in Serum or Plasma

690

4621

1.58

24.78

10.2

7.3

11.24

10.62

mmol/l

1.32

665

4413

(3025941) Bacteria identified in Stool by Culture

356

1993

1.85

24.78

1.5

1.3

—

(3022313) Gas panel - Capillary blood

382

2186

1.82

24.77

5.3

4.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1726

13852

1.40

24.62

3.8

3.3

33.42

36.55

u/l

0.65

1623

13005

(3037121) Protein [Mass/volume] in Urine

298

1588

1.94

24.12

3.6

3.1

310.45

449.10

mg/l

1.18

144

696

(3034770) Mitochondria Ab [Titer] in Serum

234

1152

2.09

23.65

1.2

674.29

961.82

titre

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

283

1495

1.95

23.50

1.4

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

792

5539

1.52

23.29

5.4

32.97

33.15

0.16

579

3531

(3017143) Hepatitis C virus Ab [Presence] in Serum

572

3759

1.60

22.10

1.6

—

(3045424) Erythrocytes [Presence] in Urine

381

2255

1.75

21.98

2.5

2.2

0.00

0.39

estimate

0.53

668

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1082

8129

1.44

21.96

3.7

3.3

0.81

mmol/l

1.01

1030

7609

(3009508) Creatinine [Moles/volume] in Urine

1960

16266

1.36

21.93

3.8

3.5

7.20

7.23

mmol/l

0.11

1693

13546

(3019225) pH of Specimen

675

4616

1.54

21.90

5.4

4.7

7.36

0.29

543

3273

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1004

7443

1.45

21.89

2.4

2.0

29.83

29.75

0.17

986

7238

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

818

5828

1.49

21.86

2.1

1.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

348

2017

1.79

21.57

1.8

1.6

13.45

16.84

iu/ml

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

252

1323

1.96

21.30

1.8

1.4

14.95

18.14

iu/ml

—

(3012516) Albumin [Mass/volume] in Urine

1919

15938

1.35

21.08

3.9

3.5

70.92

50.29

mg/l

2.57

1281

10208

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

989

7376

1.44

20.72

1.4

1.3

35.04

36.56

iu/ml

0.12

323

2225

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

242

3.26

20.44

1.4

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

594

4009

1.55

20.35

2.7

2.6

0.32

0.49

e6/l

1.83

575

3863

(3018405) Lactate [Moles/volume] in Arterial blood

292

1640

1.83

20.07

4.8

3.6

1.33

1.37

mmol/l

0.30

287

1613

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

310

1776

1.80

19.96

2.3

2.2

583.50

626.79

ug/l

0.08

297

1696

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

246

3.21

19.91

1.4

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1940

16245

1.34

19.75

4.6

4.2

11.75

9.29

mg/mmol

1.33

1298

10108

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

498

3249

1.60

19.73

4.9

3.9

5.13

5.14

kpa

0.13

479

3106

(3009343) pH of Capillary blood

486

3153

1.61

19.71

4.9

3.9

7.41

7.42

2.00

419

2624

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

297

1687

1.81

19.67

1.3

1.2

—

(3002256) Pathology report gross observation

829

6040

1.46

19.55

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

1438

11530

1.36

19.40

3.8

3.2

0.05

341

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

434

2752

1.64

19.30

4.6

3.6

1.32

1.96

mmol/l

2.88

335

2039

(3004616) Nuclear Ab [Presence] in Serum

123

511

2.45

18.72

1.3

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

259

1449

1.84

18.03

1.6

28.20

20.89

u/ml

0.57

260

(4035726) Immunohistochemistry procedure

597

4151

1.50

17.67

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

912

6877

1.41

17.59

1.4

1.3

9.42

13.64

u/ml

0.94

333

2506

(3004119) Hemoglobin [Mass/volume] in Venous blood

470

3122

1.56

17.15

4.3

3.2

124.29

127.88

g/l

2.63

464

3027

(40760892) CBC W Ordered Manual Differential panel - Blood

1123

8827

1.36

16.72

5.7

5.0

—

(3017732) Neutrophils [#/volume] in Blood

739

5416

1.44

16.63

3.2

3.4

5.71

4.73

e9/l

0.84

617

4569

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

130

584

2.26

16.61

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

130

587

2.25

16.41

1.6

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

197

1041

1.93

16.37

2.9

2.7

36.18

33.78

umol/l

0.47

172

932

(3044889) 12 lead EKG panel

3219

29371

1.33

16.34

5.5

4.6

0.46

1384.18

0.49

(3025468) Yersinia sp identified in Specimen by Organism specific culture

129

582

2.25

16.32

1.6

1.4

—

(3018418) pH of Serum or Plasma

1713

14358

1.31

16.31

5.4

4.4

7.40

0.54

1241

10394

(3000494) Fungus identified in Specimen by Culture

720

5287

1.43

15.98

1.6

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

220

1215

1.85

15.97

1.6

1.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

316

1939

1.68

15.93

1.1

0.99

1.26

u/ml

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

355

2246

1.63

15.88

2.8

2.4

3.53

3.70

g/l

1.43

327

2049

(46235355) HIV 1 and 2 tests - Meaningful Use set

657

4750

1.45

15.86

1.7

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

355

2248

1.63

15.82

2.8

2.4

4.18

4.19

g/l

0.08

328

2051

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

355

2250

1.63

15.76

2.8

2.4

7.44

7.45

g/l

0.04

328

2050

(3023420) DNA double strand Ab [Units/volume] in Serum

280

1680

1.71

15.34

1.5

1.7

5.98

6.85

iu/ml

0.26

401

(3021589) Normoblasts [#/volume] in Blood

2149

18668

1.29

15.25

14.3

12.6

0.00

e9/l

1.27

1791

15174

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

438

2952

1.54

14.92

11.0

9.9

15.58

15.84

1.30

433

2846

(3024522) Salmonella sp identified in Specimen by Organism specific culture

130

614

2.15

14.73

1.6

1.4

—

(3005570) Glucose [Moles/volume] in Urine

411

2.42

14.69

2.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

331

2103

1.62

14.54

2.6

2.4

2.87

2.92

g/l

0.38

304

1906

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

130

621

2.13

14.32

1.6

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

310

1947

1.64

14.27

2.8

2.4

0.95

0.98

g/l

0.04

276

1663

(44816559) Phosphatidylethanol [Mass/volume] in Blood

247

1465

1.73

14.12

1.7

1.6

0.32

0.33

mg/l

0.10

116

642

(3024980) IgG subclass 4 [Mass/volume] in Serum

141

702

2.04

13.92

1.9

1.6

0.75

0.86

g/l

0.47

109

542

(3008152) Bicarbonate [Moles/volume] in Arterial blood

458

3161

1.50

13.92

7.8

6.7

24.78

24.55

mmol/l

0.75

451

3027

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

127

608

2.12

13.92

1.6

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

123

583

2.14

13.83

1.1

1.54

g/l

0.05

109

526

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

535

3817

1.46

13.75

1.9

1.7

1.62

1.54

1.18

454

3248

(3036481) Cortisol [Moles/volume] in Serum or Plasma

559

4044

1.44

13.32

2.4

371.68

381.85

nmol/l

0.59

518

3724

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

649

4822

1.40

13.31

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

360

2384

1.55

13.25

1.4

1.3

201.38

214.37

u/ml

0.13

327

2203

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

208

1200

1.77

13.12

1.3

1.2

48.01

37.88

u/ml

0.23

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

198

1138

1.77

12.66

1.3

1.2

2.95

5.59

u/ml

0.40

107

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

198

1139

1.77

12.62

1.3

5.82

6.86

u/ml

0.14

178

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

300

1933

1.59

12.44

2.8

2.4

10.10

10.21

g/l

0.16

267

1713

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

374

2534

1.52

12.40

1.4

1.3

62.72

59.32

au/ml

0.10

192

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

211

1243

1.73

12.38

1.6

1.5

0.12

9.05

iu/ml

0.95

242

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

194

1119

1.77

12.26

3.3

3.4

69.62

843.47

u/ml

2.34

177

1025

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

233

2.68

11.73

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

233

2.68

11.73

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

146

783

1.89

11.69

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

194

1135

1.74

11.68

3.6

3.3

0.82

0.81

nmol/l

0.05

162

910

(3027273) Bicarbonate [Moles/volume] in Venous blood

336

2257

1.53

11.59

4.5

3.4

25.09

25.22

mmol/l

0.25

331

2187

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

398

2773

1.48

11.51

2.6

2.5

19.20

23.05

au/ml

0.37

221

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

258

1635

1.61

11.48

2.9

2.3

0.05

0.03

g/l

0.26

238

1467

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

292

1906

1.57

11.46

4.0

3.6

38.92

57.68

mg/l

1.28

262

1625

(3033099) Centromere Ab [Titer] in Serum

3.80

11.44

1.2

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

140

746

1.90

11.44

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

292

1909

1.57

11.38

4.0

3.6

97.66

79.88

mg/l

0.18

260

1628

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3328

31016

1.28

11.38

35.5

24.7

330.37

331.54

g/l

11.45

3319

30853

(3006462) Nitrate [Presence] in Urine

198

2.80

11.30

5.4

3.9

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

158

879

1.83

11.29

1.3

1.2

73.33

258.75

titre

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

209

1262

1.69

11.24

2.4

3.60

3.61

g/l

0.05

199

1203

(3003694) ABO and Rh group [Type] in Blood

1313

11040

1.27

11.11

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

459

2.14

11.03

1.5

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

169

968

1.77

10.97

1.3

1.2

1.11

5.94

u/ml

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

157

881

1.81

10.92

1.3

1.2

107.69

342.11

titre

2.11

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

275

1798

1.56

10.73

2.7

—

(3026782) Osmolality of Urine

1095

9040

1.28

10.69

3.7

3.1

520.55

528.02

mosm/kgh2o

0.59

960

7940

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

175

1021

1.74

10.67

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

232

1460

1.62

10.63

2.9

2.3

0.00

g/l

-0.00

222

1375

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

161

918

1.78

10.63

6.6

5.1

488.87

3148.74

iu/ml

0.77

137

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1800

15752

1.24

10.55

6.9

6.1

4.11

3.39

ug/l

0.16

1652

14165

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

320

2176

1.51

10.43

2.1

1.9

1.24

2.46

ug/l

2.50

294

1926

(3024139) IgG subclass 3 [Mass/volume] in Serum

430

2.14

10.41

1.6

1.4

0.35

0.41

g/l

1.02

310

(3027135) IgG subclass 1 [Mass/volume] in Serum

430

2.14

10.41

1.6

1.4

6.46

6.99

g/l

0.82

310

(3028192) IgG subclass 2 [Mass/volume] in Serum

430

2.14

10.41

1.6

1.4

2.64

2.94

g/l

1.08

311

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

118

614

1.95

10.39

3.1

2.1

21.95

23.84

mg/l

0.21

212

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

334

2.30

10.37

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

316

2.33

10.31

1.3

30.67

34.64

u/l

0.42

262

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

329

2.30

10.28

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

244

2.52

10.23

2.1

2.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

453

2.10

10.23

1.3

1.1

37.00

42.54

u/ml

—

(4211845) Urine protein measurement

215

2.62

10.21

5.4

3.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

356

2486

1.47

10.17

1.4

—

(3049717) Cytology report of Urine Cyto stain

297

1999

1.52

10.17

3.0

2.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

488

2.05

10.15

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

244

1574

1.58

10.10

2.8

2.3

0.00

g/l

0.50

223

1377

(4146454) Self-monitoring of blood glucose

107

546

1.98

9.98

2.4

2.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1154

9688

1.26

9.64

1.8

70443277.44

27223711.68

pmol/l

1.00

971

7905

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

157

917

1.74

9.57

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

342

2399

1.46

9.55

3.3

3.4

4.34

4.39

pmol/l

0.39

305

2118

(4062490) Immunoglobulin typing, IgG

427

2.08

9.44

1.5

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

107

558

1.94

9.40

2.0

2.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

258

1714

1.54

9.39

4.0

3.4

10.07

2.86

ratio

0.81

167

981

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

459

2.03

9.17

3.3

3.0

—

(3036489) Thrombin time

238

1566

1.55

9.06

2.1

2.0

21.57

21.27

0.20

218

1407

(3044927) Protein electrophoresis panel - Urine

102

533

1.93

8.92

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

105

558

1.90

8.75

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

173

1065

1.65

8.71

1.5

1.4

—

(3011985) Renin [Units/volume] in Plasma

117

645

1.84

8.70

1.5

1.4

78.24

71.44

mu/l

0.10

108

573

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

134

771

1.76

8.65

1.3

1.4

—

(40768443) Skin Pathology biopsy report

300

2097

1.46

8.55

1.3

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

269

1843

1.49

8.49

1.7

1.9

39.56

39.09

u/l

0.14

237

1605

(3006270) Folate [Moles/volume] in Blood

365

2.10

8.42

1.3

1.2

336.29

350.15

nmol/l

0.24

298

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

102

545

1.89

8.37

1.3

—

nmol/l

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

149

893

1.69

8.32

1.1

6.50

8.38

eliau/ml

0.21

(3015171) Extractable nuclear Ab [Units/volume] in Serum

237

1590

1.52

8.28

1.2

0.33

1.30

u/ml

1.97

134

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

200

1294

1.57

8.23

1.6

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1939

17391

1.20

8.18

2.0

1.35

1.33

mmol/l

0.31

1653

14262

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

115

644

1.81

8.15

1.3

0.64

3.40

nmol/l

0.50

107

618

(40757494) Bilirubin.total [Moles/volume] in Blood

241

2.34

8.10

3.0

2.2

15.46

23.05

umol/l

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

178

1126

1.60

8.06

1.9

2.0

13.45

12.21

mg/l

1.17

165

1037

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

117

663

1.79

7.98

1.3

0.12

0.31

nmol/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

104

569

1.85

7.95

2.0

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

147

890

1.67

7.92

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

269

1869

1.47

7.92

2.2

1.9

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

204

1343

1.54

7.79

2.9

2.8

1.93

1.71

mg/l

2.23

186

1204

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1090

9285

1.23

7.71

5.2

4.2

363.44

470.24

ng/l

0.30

928

7836

(3017704) Immunofixation for Urine

279

2.20

7.67

1.6

—

(3037756) Immunofixation for Serum or Plasma

178

1147

1.57

7.48

1.6

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

244

2.27

7.45

2.1

1.8

388.98

330.51

mu/l

0.36

189

(3000475) Leukocytes [#/volume] in Synovial fluid

186

1213

1.56

7.42

1.8

1.6

12989.49

12568.61

e6/l

0.05

128

845

(3000093) Morphology [Interpretation] in Blood Narrative

461

1.90

7.37

1.2

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

106

599

1.79

7.33

1.3

318.91

297.10

pmol/l

0.22

504

(40768441) Liver Pathology biopsy report

311

2.11

7.32

1.5

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

165

1054

1.59

7.21

1.7

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

190

1254

1.54

7.20

1.6

1.5

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

118

2.81

6.99

10.0

7.6

63.27

73.60

1.20

(3033705) Calcium.ionized [Moles/volume] in Venous blood

542

1.81

6.98

2.4

2.3

1.19

1.20

mmol/l

0.52

534

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.15

6.97

1.7

2.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

176

1151

1.55

6.96

2.5

2.4

212.36

205.61

0.40

169

1096

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1437

12689

1.19

6.86

5.5

4.9

22.16

22.12

0.04

817

6759

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.14

6.70

1.7

2.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

542

1.79

6.70

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1080

9306

1.21

6.68

3.5

0.80

ug/l

0.03

829

6558

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

246

1739

1.44

6.66

2.0

1.8

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

139

2.60

6.61

1.1

1.50

2.94

u/ml

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

324

2.02

6.60

1.2

95.00

104.81

titre

—

(3035285) Chloride [Moles/volume] in Venous blood

555

1.76

6.48

2.4

2.3

105.71

105.31

mmol/l

0.44

547

(3041354) Potassium [Moles/volume] in Venous blood

555

1.76

6.48

2.4

2.3

4.04

4.08

mmol/l

0.49

547

(3038026) Centromere Ab [Units/volume] in Serum

327

2.00

6.45

1.4

1.2

20.86

61.26

u/ml

—

(44790049) Parainfluenza type 3 nucleic acid detection

101

586

1.74

6.43

1.6

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

101

586

1.74

6.43

1.6

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

101

586

1.74

6.43

1.6

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

101

586

1.74

6.43

1.6

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

184

1239

1.51

6.39

2.3

2.1

91.76

90.57

0.30

177

1197

(21494434) Karyotype in Bone marrow

479

1.81

6.30

1.1

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

111

667

1.68

6.24

1.3

1.4

146.41

155.57

au/ml

0.32

193

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

569

1.74

6.24

1.3

0.22

nmol/l

0.05

459

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3313

31517

1.19

6.19

31.4

23.4

14.05

13.80

18.44

3283

31093

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

115

700

1.66

6.16

2.2

1.8

—

(4024509) Urine culture

302

2245

1.37

6.13

2.0

2.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

142

914

1.57

6.07

1.4

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

208

2.22

6.03

1.0

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

123

769

1.62

5.95

1.4

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

447

1.80

5.83

1.7

1.4

96039.53

103788.11

e6/l

0.05

305

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

106

644

1.66

5.75

1.2

272.48

291.28

u/ml

0.25

376

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

322

1.94

5.67

1.0

275.37

288.72

mg/l

0.87

287

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

215

2.15

5.59

2.2

1.6

38.84

40.10

g/l

0.76

215

(3010838) Calcium [Moles/time] in 24 hour Urine

122

774

1.59

5.58

1.8

1.9

4.39

4.74

mmol/24h

0.62

105

664

(3017315) Amylase [Enzymatic activity/volume] in Urine

204

2.17

5.46

1.2

168.78

322.30

u/l

1.58

188

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

285

1.98

5.44

1.5

1.6

6.78

7.06

u/l

0.06

231

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

177

1225

1.46

5.42

1.6

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

166

1135

1.48

5.41

5.4

4.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

415

3291

1.29

5.39

2.6

2.3

12.48

12.71

nmol/l

0.20

362

2895

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

168

2.27

5.29

1.9

2.2

477.50

18780.33

u/ml

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

137

2.42

5.28

1.1

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

131

858

1.54

5.24

1.2

13.51

45.66

u/ml

—

100

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

578

4783

1.24

5.24

1.5

1.4

—

(3017354) Segmented neutrophils/Leukocytes in Blood

538

1.69

5.22

3.8

3.6

58.79

58.11

0.10

453

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

427

1.77

5.18

1.6

1.7

23.00

25.73

u/ml

0.25

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

115

735

1.58

5.13

2.8

2.5

1718.50

2596.08

u/ml

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

482

1.71

5.07

4.0

—

(4015189) Microbial culture of sputum

128

2.43

5.03

2.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

106

669

1.60

4.99

1.8

2.4

0.83

1.21

g/24h

1.77

385

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

109

694

1.58

4.95

6.9

6.3

12.44

12.21

mg/l

0.19

646

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

100

2.61

4.88

1.1

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

130

870

1.51

4.74

1.6

—

(40762887) Creatinine [Moles/volume] in Blood

4.42

4.74

1.7

1.8

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

136

922

1.49

4.67

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

136

922

1.49

4.67

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

135

921

1.48

4.51

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

393

1.74

4.51

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

393

1.74

4.51

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

393

1.74

4.51

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

126

848

1.50

4.50

1.4

1.6

0.95

0.84

nmol/l

0.83

100

715

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

117

776

1.52

4.48

2.1

1.9

188.01

200.35

pmol/l

0.73

107

721

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

168

2.15

4.45

2.2

2.7

0.59

0.60

mmol/l

0.39

168

(4094501) Cardiovascular stress test using bicycle ergometer

169

1207

1.42

4.44

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

358

1.77

4.43

1.3

1.4

281.67

373.14

titre

—

(3010375) cycloSPORINE [Mass/volume] in Blood

183

2.09

4.35

37.7

27.0

118.31

111.45

ug/l

0.27

149

(3047189) Immunofixation for 24 hour Urine

269

1.87

4.21

1.3

1.7

—

(3032057) Clostridioides difficile [Presence] in Stool

103

2.44

4.13

1.9

2.0

—

(3017181) Myelocytes/Leukocytes in Blood

502

4201

1.22

4.09

5.1

4.4

1.02

0.96

0.20

192

1350

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

156

1117

1.41

4.07

2.6

2.3

174.86

94.72

ug/min

1.13

656

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

398

1.69

4.06

1.0

1.1

2.86

2.53

eliau/ml

0.15

143

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

376

1.71

4.04

1.9

1.7

1067.69

2046.71

u/l

0.51

140

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

494

4134

1.22

4.03

3.5

3.1

234.41

210.46

ng/l

0.58

457

3817

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

252

1.87

4.01

2.7

2.1

256.82

233.33

e6/l

0.22

222

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

131

911

1.45

4.01

1.3

27.54

39.68

u/l

1.15

121

782

(3009214) Lutropin [Units/volume] in Serum or Plasma

108

725

1.50

3.95

1.3

1.4

12.51

11.22

u/l

0.38

585

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

240

1.88

3.91

1.5

9.18

5.97

u/l

0.39

206

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.79

3.88

2.3

1.4

—

(3036603) Volume of Urine

351

1.72

3.86

1.5

1.7

1765.77

1886.31

0.72

343

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

193

1448

1.35

3.81

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

167

2.04

3.74

1.3

—

(3002179) Metamyelocytes/Leukocytes in Blood

476

4003

1.21

3.71

4.9

4.3

0.55

0.74

2.12

183

1275

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

100

672

1.50

3.67

1.4

1.2

276.17

203.74

miu/ml

0.98

254

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

253

1.83

3.66

2.5

2.0

406.89

490.87

e6/l

0.75

208

(3004809) Band form neutrophils/Leukocytes in Blood

121

846

1.44

3.63

3.6

3.7

1.85

1.79

0.06

110

749

(3016650) Hepatitis A virus Ab [Presence] in Serum

635

1.51

3.58

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

557

1.54

3.52

1.2

3.95

5.15

u/ml

0.34

241

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

425

1.61

3.45

1.2

—

(3022621) pH of Urine by Test strip

410

3423

1.22

3.45

3.2

2.9

6.03

6.05

0.18

249

2412

(3026250) Tacrolimus [Mass/volume] in Blood

159

2.02

3.44

36.8

36.2

6.95

7.17

ug/l

0.19

143

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

258

2048

1.28

3.41

3.6

4.1

67.40

79.05

u/ml

0.19

247

1975

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

643

1.49

3.39

1.2

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

120

2.17

3.37

1.8

1.6

3977.14

titre

—

(3036670) Protein [Mass/volume] in Synovial fluid

154

2.02

3.34

1.5

1.2

37.51

39.57

g/l

0.25

(3000330) Specific gravity of Urine by Test strip

296

2399

1.25

3.30

4.6

3.5

1.02

ratio

0.97

266

2175

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

518

1.53

3.28

3.9

3.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

206

1601

1.30

3.23

1.8

1.7

—

(3042631) Mycobacterium sp identified in Specimen

683

1.46

3.23

2.5

3.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

332

1.66

3.22

1.1

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

402

1.60

3.21

1.8

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

169

1280

1.33

3.19

4.1

3.4

2.06

2.08

index

0.01

659

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

443

1.57

3.16

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

229

1.80

3.15

1.1

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.73

3.15

1.3

1.5

43.33

45.36

umol/l

0.11

(3021440) Promyelocytes/Leukocytes in Blood

470

4011

1.19

3.15

5.2

4.4

0.13

0.12

0.07

163

1165

(3045142) Bone marrow Pathology biopsy report

606

1.48

3.11

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

123

891

1.39

3.09

1.2

1.1

15.16

3.30

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

665

1.45

3.08

1.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

478

1.54

3.08

1.2

—

(3042733) HLA Ab [Presence] in Serum

112

2.15

3.06

4.8

4.9

—

(3041672) Baker's yeast Ab [Presence] in Serum

5.01

3.05

1.0

—

(3011412) CD3 cells [#/volume] in Blood

384

1.60

3.05

2.4

2.0

993.65

1088.35

e6/l

0.58

342

(3024891) Influenza virus A+B Ag [Presence] in Specimen

120

868

1.39

3.04

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

370

1.60

3.00

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

182

1.87

3.00

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

211

1.81

2.99

2.2

1.7

0.58

2.68

u/field

5.06

145

(40761536) Microorganisms panel - Urine sediment

279

3400

0.81

2.98

5.1

4.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

566

1.48

2.91

1.2

2.52

3.34

u/ml

0.44

189

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

146

1108

1.33

2.76

1.6

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

263

2151

1.24

2.75

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

294

1.64

2.71

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

256

1.69

2.70

3.2

1.9

16.74

16.07

nmol/l

0.23

236

(3022689) Creatine [Moles/volume] in Urine

153

1.90

2.70

1.4

1.5

5.97

7.18

mmol/l

0.61

153

(1761868) Lipid panel - Serum or Plasma

1214

13122

0.90

2.65

3.7

3.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

263

2163

1.23

2.62

5.2

5.3

0.88

0.87

0.13

258

2043

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

221

1.73

2.60

1.3

2.8

204.03

202.26

u/l

0.06

216

(3020393) Adenovirus Ag [Presence] in Stool

3.34

2.60

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

244

1.69

2.59

2.8

2.5

39.52

38.93

0.08

134

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

292

1.62

2.53

2.1

1.9

—

(3050794) Legionella sp Ab [Presence] in Serum

2.98

2.48

1.1

1.0

—

(21494815) CD4 cells/Lymphocytes in Specimen

325

1.58

2.48

1.7

2.0

38.36

39.33

0.15

319

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.47

2.48

2.0

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

629

1.41

2.46

1.6

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

130

1.93

2.45

1.1

—

(3020491) Glucose [Moles/volume] in Blood

295

1.60

2.44

1.4

2.4

7.98

6.78

mmol/l

1.35

197

(3003434) Protein [Mass/volume] in Pleural fluid

107

792

1.36

2.43

1.6

1.5

29.95

32.00

g/l

1.01

100

714

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

125

949

1.33

2.40

1.3

—

(3025159) Blasts/Leukocytes in Blood

462

4036

1.16

2.37

5.3

4.6

0.11

0.33

1.10

155

1106

(3021788) Differential panel - Synovial fluid

116

873

1.34

2.37

1.7

1.5

—

1.00

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

118

1.95

2.35

1.6

2.4

188.22

196.11

0.14

111

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

161

1.81

2.34

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

403

1.50

2.33

3.4

3.2

19.53

32.08

mg/l

0.85

311

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

144

1124

1.29

2.28

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

155

1222

1.28

2.27

1.9

2.3

126.59

127.67

g/l

0.19

105

941

(3019832) Treponema pallidum Ab [Presence] in Serum

193

1563

1.25

2.26

1.5

—

(3000012) Reticulocyte production index

106

795

1.34

2.24

2.0

2.2

0.98

0.89

0.98

549

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.34

2.21

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

257

1.60

2.17

1.2

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

257

1.60

2.17

1.2

1.4

—

(3028433) Virus identified in Specimen by Culture

136

1.84

2.17

1.0

1.2

—

(40768446) Kidney Pathology biopsy report

158

1.78

2.17

1.4

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

535

1.41

2.16

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

378

1.49

2.15

1.1

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

595

1.39

2.14

1.5

32650.96

71059.33

e6/l

0.98

323

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

282

1.57

2.13

1.4

1.3

1.28

1.41

u/ml

0.05

168

(3020911) Cortisol [Moles/time] in 24 hour Urine

130

1.85

2.12

1.0

1.5

76.00

491.85

nmol/24h

1.09

130

(3023419) Bacteria identified in Sputum by Culture

665

1.36

2.11

2.9

2.6

—

(3024932) HLA-DR beta [Type]

102

1.97

2.10

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.14

2.08

1.1

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

676

1.35

2.07

1.5

2967.80

3403.87

e6/l

0.09

467

(3034274) Bile acid [Moles/volume] in Serum --fasting

206

1.66

2.07

1.7

1.5

8.63

13.11

umol/l

0.52

138

(40762814) Titanium [Mass/volume] in Blood

2.08

2.06

2.5

2.3

2.90

4.00

ug/l

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

230

1.61

2.04

6.5

6.8

41.56

100.84

ug/l

0.33

139

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.11

2.02

1.4

1.2

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

3.08

2.01

1.1

1.0

—

3.10

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.64

2.00

1.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

536

1.39

1.98

1.7

1.5

55.69

60.55

0.47

340

(3020191) Ethanol [Moles/volume] in Serum or Plasma

305

1.51

1.95

1.2

1.4

1.05

1.02

promille

0.06

238

(3051611) Lipemic interference index of Serum or Plasma

462

1.41

1.94

3.6

3.3

13.41

11.85

index

0.77

255

(3026692) Albumin [Mass/volume] in Peritoneal fluid

149

1.75

1.94

1.7

1.4

12.50

13.99

g/l

0.41

115

(3009466) Valproate [Moles/volume] in Serum or Plasma

549

1.37

1.89

4.6

5.0

342.40

346.91

umol/l

0.11

478

(4268621) Lupus anticoagulant assay

398

1.44

1.88

2.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

627

1.35

1.88

1.6

—

(3025577) Chromium [Mass/volume] in Blood

316

1.49

1.87

2.4

2.2

1.74

2.17

ug/l

0.78

265

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

136

1.77

1.87

1.5

1.6

0.50

0.40

ug/l

0.30

(3022493) Free Hemoglobin [Mass/volume] in Plasma

197

1.63

1.86

11.9

4.6

72.57

62.20

mg/l

0.36

137

(3024471) HLA-A [Type]

107

1.87

1.86

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

174

1.67

1.85

1.8

1.7

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

213

1.60

1.85

1.0

1.2

—

(3048879) Bone marrow aspiration report

137

1.76

1.83

1.7

1.6

—

2.00

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.17

1.82

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.17

1.82

2.0

1.3

22.22

33.61

umol/24h

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

183

1.64

1.81

1.1

646.40

353.32

ng/l

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

160

1.69

1.81

1.6

2.3

178.41

169.58

0.21

150

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

435

1.41

1.81

1.5

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

247

1.54

1.78

1.4

1.27

1.18

nmol/l

0.13

175

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

337

1.46

1.77

5.3

5.4

22.16

44.71

u/ml

1.86

100

(40759836) Histone Ab [Presence] in Serum by Immunoblot

329

1.46

1.76

1.1

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.34

1.74

1.0

1.1

227.00

261.61

nmol/l

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

117

1.80

1.74

1.8

1.5

9.07

9.36

ug/l

0.17

117

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.67

1.72

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.67

1.72

1.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

186

1.62

1.71

2.0

1.4

23.70

29.28

umol/l

2.37

176

(3035637) Corticotropin [Mass/volume] in Plasma

568

1.34

1.71

1.4

1.6

33.23

29.21

ng/l

0.14

568

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.13

1.71

1.1

1.2

65.29

76.94

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

134

1081

1.25

1.70

1.2

688.44

582.71

mg/l

0.22

126

1020

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

340

1.45

1.70

1.1

1.2

—

(3003181) Sodium [Moles/volume] in Urine

124

992

1.26

1.69

1.4

55.20

61.45

mmol/l

1.49

101

806

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

203

1.58

1.67

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

203

1.58

1.67

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

172

1.63

1.66

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

172

1.63

1.66

1.7

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.10

1.65

1.1

1.3

82.29

76.89

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

342

3872

0.87

1.64

5.3

4.2

1.22

1.23

mmol/l

1.05

309

3347

(3023383) Lactate [Moles/volume] in Pleural fluid

158

1.65

1.62

1.3

1.4

2.43

3.24

mmol/l

1.51

143

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.38

1.61

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

131

1062

1.24

1.61

1.8

1.9

2.75

9.64

iu/l

0.64

404

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

166

1.63

1.61

1.0

1.1

1599.11

1633.99

miu/ml

0.05

166

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.69

1.58

1.1

1.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

542

1.33

1.57

1.4

236.96

335.57

u/l

1.78

515

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.20

1.56

2.3

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

364

1.41

1.54

1.8

2.0

3.32

1.51

u/field

0.74

188

(3023511) Choriogonadotropin [Units/volume] in Urine

153

1.64

1.53

1.6

1.3

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

1.51

0.0

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

434

1.36

1.51

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

324

1.42

1.50

1.1

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.86

1.50

1.3

5.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.16

1.50

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

125

1018

1.23

1.49

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

435

1.36

1.49

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

101

1.79

1.48

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

470

1.35

1.48

1.2

1.3

—

(3012441) Differential panel - Pleural fluid

592

1.31

1.47

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

360

1.39

1.46

1.1

—

(3008898) HLA-B27 [Presence]

125

1022

1.23

1.45

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

310

1.42

1.45

1.1

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.12

1.44

1.3

1.2

110.40

134.38

ug/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1206

11421

1.08

1.41

4.3

3.7

0.04

0.18

estimate

0.78

332

3765

(3006653) Thiamine [Moles/volume] in Blood

229

1.49

1.41

1.1

1.2

153.18

137.74

nmol/l

1.04

229

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

221

1.50

1.40

1.8

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

1.85

1.40

2.2

1.9

0.18

0.15

e9/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.85

1.40

1.7

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

246

1.47

1.39

2.2

2.0

110.00

215.81

ug/min

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

238

1.47

1.39

1.0

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

305

1.41

1.38

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

265

2326

1.15

1.38

1.2

103.49

134.34

u/ml

0.71

108

811

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

324

1.39

1.33

1.1

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

224

1.48

1.33

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

152

1.58

1.31

2.0

2.6

4.87

4.89

kpa

0.05

152

(3004775) Volume in Urine collected for unspecified duration

368

1.36

1.31

2.6

2.3

814.97

630.57

1.41

235

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.50

1.30

1.0

1.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

153

1.57

1.28

2.0

2.6

10.04

9.99

kpa

0.04

153

(40768806) Pleura Pathology biopsy report

588

1.28

1.5

1.6

—

(4195642) Thrombophilia screening test

509

1.30

1.27

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.00

1.23

1.9

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.00

1.23

1.9

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.00

1.23

1.9

1.1

—

(3004451) EKG impression Narrative

313

1.38

1.22

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

382

1.34

1.21

1.5

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

305

1.38

1.21

1.1

3.42

2.00

u/ml

0.28

132

(3002079) Sodium [Moles/time] in 24 hour Urine

188

1.49

1.21

1.3

141.57

159.10

mmol/24h

0.66

188

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

221

1.45

1.20

2.5

3.5

1.63

1.30

0.50

221

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.11

1.18

3.8

2.3

0.38

0.47

u/field

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

157

1.53

1.17

2.2

1.9

3240.06

20093.51

e6/l

0.73

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

333

1.35

1.16

1.4

1.5

—

(1002224) Polysomnography panel

166

1429

1.17

1.16

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

351

1.34

1.15

2.1

2.3

9.54

33.42

iu/ml

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

174

1.50

1.15

1.6

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

174

1.50

1.15

1.3

1.2

129.07

374.51

ug/l

0.60

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

317

1.36

1.14

1.7

1.8

98.36

115.40

ng/l

0.62

317

(3008536) Aspergillus sp Ab [Presence] in Serum

1.69

1.13

1.8

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

318

1.36

1.12

1.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

208

1.45

1.12

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.34

1.12

1.4

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

520

1.27

1.11

1.1

1.35

1.66

u/ml

0.16

283

(40761539) Cells [Type] in Urine sediment by Light microscopy

115

0.43

1.11

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

127

1.58

1.11

1.1

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

521

1.27

1.10

1.1

1.2

121.38

114.52

0.93

462

(3003888) Timothy IgE Ab [Units/volume] in Serum

416

1.30

1.08

1.0

1.1

2.27

3.20

u/ml

0.26

198

(40765089) Chromosome analysis panel - Blood by G-banded

2.19

1.08

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.65

1.06

1.1

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

114

960

1.19

1.05

1.2

3.82

3.84

mmol/l

0.08

108

901

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

228

1.41

1.05

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.67

1.04

1.1

1.2

0.87

0.70

umol/24h

—

(3002619) Bacteria identified in Specimen by Culture

1.63

1.03

1.3

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

138

1.52

1.02

14.0

13.7

0.61

0.63

mmol/l

0.16

128

(3006442) Creatine [Moles/volume] in Serum or Plasma

263

0.65

1.01

1.4

1.6

78.71

87.56

umol/l

1.75

263

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

230

1.39

1.01

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.89

1.01

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.77

1.00

10.3

14.1

4.40

5.30

mmol/l

1.29

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.00

1.00

1.0

1.1

—

193.75

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

2.00

1.00

1.7

1.3

0.56

0.81

ml/s/173m2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.18

0.98

1.0

2.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

672

0.79

0.97

1.2

0.54

0.62

ratio

0.82

126

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

155

1351

1.15

0.96

1.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

407

1.28

0.96

1.0

1.1

0.50

1.10

u/ml

1.03

168

(3023410) Appearance of Cerebral spinal fluid

407

1.28

0.96

1.3

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

174

1.44

0.95

1.4

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.65

0.94

1.3

1.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.78

0.94

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.61

0.93

1.2

1.4

—

(3016879) Cocaine [Presence] in Urine

462

1.26

0.93

1.4

1.7

—

(3044009) aPTT.lupus sensitive (LA screen)

2.22

0.93

1.2

—

(3016750) Collection duration of Urine

260

1.35

0.93

2.6

2.1

496.96

492.61

min

0.10

189

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.73

0.92

1.3

1.2

4.59

7.76

mg/l

—

(37021550) Renin [Units/volume] in Plasma --upright

102

1.57

0.90

1.1

1.3

21.18

55.81

mu/l

1.86

(3046861) Legionella sp Ag [Presence] in Urine

2.07

0.89

1.2

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

202

1.39

0.89

1.3

1.5

205.74

201.26

pmol/l

0.03

202

(4034850) Laboratory test

148

1296

1.15

0.88

13.0

11.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

228

1.36

0.88

1.7

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

228

1.36

0.88

1.7

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

228

1.36

0.88

1.7

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

228

1.36

0.88

1.7

1.9

—

(44813793) Dust mix specific IgE antibody measurement

254

1.34

0.88

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

119

1.51

0.88

1.0

1.1

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

169

1.42

0.87

1.5

0.48

2.55

2.89

144

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.86

0.87

1.9

1.7

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

144

1.46

0.87

1.3

1.4

57.96

54.90

0.14

120

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

203

1.38

0.87

6.6

4.8

40.00

60.10

u/ml

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

115

990

1.17

0.86

1.5

1.7

—

30.85

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

541

1.22

0.85

1.3

1.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

187

1.39

0.85

2.6

2.1

1403.00

5012.17

e6/l

0.40

128

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

397

1.26

0.84

1.4

14.14

13.16

u/l

0.51

380

(3014133) Dog dander IgE Ab [Units/volume] in Serum

326

1.29

0.84

1.0

1.1

2.91

2.08

u/ml

0.22

161

(3021387) Prolactin [Units/volume] in Serum or Plasma

716

1.19

0.83

2.0

1.8

314.01

301.58

mu/l

0.11

663

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

345

1.28

0.82

1.3

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

121

1.49

0.82

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

105

1.53

0.81

1.6

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.70

0.80

1.4

1.6

—

(21491868) Cryoglobulin [Mass/volume] in Serum

164

1.40

0.79

1.1

1.3

—

0.22

g/l

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.79

0.0

1.4

—

0.16

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.82

0.79

1.5

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

321

1.28

0.79

1.3

1.5

0.22

0.28

nmol/l

0.67

230

(4212803) Bone marrow aspirate examination

1.67

0.78

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

492

1.22

0.78

1.4

1.6

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

1.56

0.78

1.6

1.5

8.86

8.34

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

613

1.19

0.76

1.1

217.31

1142.19

iu/ml

—

116

(40765096) Chromosome analysis panel by Banding

166

1.39

0.75

1.3

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

218

1.33

0.75

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

218

1.33

0.75

1.3

1.5

—

(3014271) Vancomycin [Susceptibility]

253

1.31

0.74

2.6

2.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

184

1.36

0.73

1.6

2.2

61.08

129.76

umol/l

0.97

108

(40768793) Breast Pathology biopsy report

118

1035

1.14

0.72

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.00

0.72

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

344

1.25

0.71

2.3

2.9

22.23

32.11

mg/l

1.13

257

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.58

0.71

1.1

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

203

1.33

0.70

1.6

1.5

60.13

66.47

0.37

165

(3028300) Cannabinoids [Presence] in Urine

499

1.21

0.70

1.4

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

921

0.86

0.69

1.4

32.38

33.41

iu/l

0.10

795

(3019174) dRVVT (LA screen)

1.85

0.68

1.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.64

0.68

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.60

0.68

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

275

1.27

0.68

1.0

1.1

0.76

0.26

u/ml

0.45

105

(3025549) Creatine [Moles/time] in 24 hour Urine

1.63

0.66

1.6

1.4

—

(3027008) Opiates [Presence] in Urine

494

1.20

0.66

1.4

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.59

0.65

1.1

2.21

1.78

umol/24h

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.61

0.65

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

103

1.46

0.65

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

189

1.32

0.64

1.2

—

(3017569) Oxygen content in Arterial blood

314

1.24

0.63

2.5

2.2

15.58

16.09

0.54

314

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

105

927

1.14

0.62

1.3

1.4

693.88

1165.15

e6/l

0.39

723

(3000764) Benzodiazepines [Presence] in Urine

498

1.19

0.61

1.4

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

104

918

1.14

0.61

1.3

5.47

31.03

e6/l

1.96

669

(3036525) Urea [Moles/time] in 24 hour Urine

1.67

0.61

3.8

3.3

—

(1616796) Gas panel - Central venous blood

123

1098

1.12

0.61

3.6

4.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.50

0.59

1.2

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

201

1.30

0.58

1.3

1.7

1.30

9.97

nmol/l

2.08

168

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.51

0.58

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

744

0.86

0.57

1.2

1.50

1.55

g/l

0.71

744

(3003329) Lymphocytes/Leukocytes in Synovial fluid

410

1.20

0.57

1.6

1.5

25.63

30.07

0.44

252

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

1.39

0.56

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.58

0.54

1.2

16.67

10.79

u/l

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

142

1.34

0.54

1.2

8.93

12.89

pmol/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

132

1194

1.11

0.54

1.6

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.50

0.54

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

358

1.20

0.54

1.4

1.2

—

(4198724) Urine methamphetamine measurement

1.52

0.52

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

305

1.21

0.51

2.1

1.9

8.02

8.25

mmol/l

0.13

305

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.46

0.50

1.5

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

269

0.78

0.50

3.4

4.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

334

1.20

0.49

1.7

2.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

127

1.34

0.49

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

101

1.39

0.49

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.52

0.48

2.0

2.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

281

1.21

0.47

1.2

1.1

2.03

15.93

nmol/l

1.51

(3051101) Glucose [Moles/volume] in Cord blood

0.62

0.45

4.4

6.1

7.52

8.17

mmol/l

—

(3024263) Appearance of Synovial fluid

246

1.22

0.45

1.2

1.6

—

(3045788) Cell count panel - Pleural fluid

562

1.14

0.45

1.4

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

103

1.36

0.45

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

103

1.36

0.45

1.1

1.4

83.00

82.69

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

366

1.18

0.45

1.1

1.2

104.72

102.64

pmol/l

0.13

366

(3045716) Anion gap in Serum or Plasma by calculation

553

1.14

0.44

2.6

3.3

11.36

10.70

mmol/l

0.75

546

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.45

0.44

1.0

1.1

1.13

0.36

u/ml

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

554

1.14

0.44

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

341

1.17

0.42

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.52

0.41

1.2

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

4.8

—

3.79

—

(3025130) Human papilloma virus identified in Specimen

379

1.16

0.41

1.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

168

1.25

0.40

1.1

—

(3016038) Potassium [Moles/volume] in Urine

352

1.17

0.40

1.1

37.10

35.11

mmol/l

0.24

305

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

149

0.74

0.40

1.2

1.5

0.72

1.12

ratio

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

149

0.74

0.40

1.2

1.5

0.93

0.96

ratio

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

149

0.74

0.40

1.2

1.5

0.78

1.20

ratio

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

540

1.13

0.40

1.2

1.1

20.89

25.04

au/ml

0.11

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

446

1.15

0.39

1.2

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.43

0.39

2.0

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.39

1.6

2.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

148

0.74

0.38

1.2

1.5

—

(3013727) Leukocytes other/Leukocytes in Blood

160

1.25

0.38

2.7

3.6

54.67

53.35

0.10

152

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

308

1.17

0.37

1.4

1.6

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

125

1.28

0.37

1.2

1.3

54.44

32.58

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

143

1.26

0.36

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

555

1.12

0.35

11.3

18.5

7.48

7.40

mmol/l

0.07

463

(3047352) Trisomy 18 risk [Likelihood] in Fetus

124

0.73

0.35

1.2

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

920

0.91

0.34

4.7

3.7

30.81

28.49

mg/l

0.21

642

(3028271) Lactate [Moles/volume] in Capillary blood

766

1.10

0.34

1.9

1.70

1.68

mmol/l

0.07

742

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

100

1.30

0.33

1.2

86.17

83.18

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

293

1.16

0.33

2.2

1.8

—

(21494755) Public health laboratory ask at order entry panel

180

1906

0.94

0.32

1.3

1.4

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.28

0.32

1.2

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.28

0.32

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.28

0.32

2.0

2.1

16.98

19.11

umol/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

456

1.12

0.31

1.2

—

(44806420) Estimation of glomerular filtration rate

362

1.13

0.30

2.6

2.5

—

(3052592) Norovirus Ag [Presence] in Stool

1.31

0.30

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

102

1.28

0.30

1.4

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

203

1.18

0.29

1.0

1.1

0.94

1.20

u/l

—

102

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.25

0.29

1.1

1.2

—

0.60

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

297

1.15

0.29

1.5

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

107

0.75

0.29

1.1

1.4

1.19

1.17

mmol/l

—

107

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

139

1.22

0.29

1.2

1.3

135.42

121.37

nmol/l

0.13

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

260

1.15

0.28

1.7

1.8

—

(3001186) Copper [Moles/volume] in Serum or Plasma

103

1.26

0.28

1.1

16.56

16.25

umol/l

0.14

(40758292) HTLV I+II Ab panel - Serum

1.32

0.28

1.1

1.4

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.23

0.27

1.1

1.4

1262505.15

149062.87

nmol/l

—

(21494814) CD8 cells/Lymphocytes in Specimen

168

1.19

0.27

1.7

1.9

23.85

30.29

1.18

168

(3043238) Trisomy 21 risk [Likelihood] in Fetus

128

0.78

0.26

1.2

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

112

1050

1.07

0.26

2.6

2.7

16.18

16.14

0.05

112

1029

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

426

0.89

0.26

1.1

1.2

7.43

7.57

mmol/l

0.11

363

(42529582) MDA5 Ab [Presence] in Serum by Line blot

138

0.80

0.25

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

138

0.80

0.25

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

138

0.80

0.25

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

138

0.80

0.25

1.1

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

192

0.83

0.25

1.1

1.3

5.90

6.15

mmol/l

0.73

181

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

124

1.21

0.24

1.3

1.6

—

(3006576) Bicarbonate [Moles/volume] in Blood

147

0.82

0.23

8.2

7.0

25.11

24.59

mmol/l

0.24

131

(3035933) Granulocytes/Leukocytes in Blood

892

1.07

0.23

3.7

3.4

59.87

58.28

0.64

892

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

125

0.80

0.23

8.1

7.3

6.10

5.95

kpa

—

109

(46235168) Fasting glucose [Moles/volume] in Blood

1.28

0.23

1.4

1.5

6.68

8.11

mmol/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

117

1107

1.06

0.22

1.7

5.49

4.82

mg/l

0.12

842

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.25

0.22

1.4

1.1

0.04

0.03

u/ml

—

(4133840) Spirometry

1.27

0.22

1.1

1.2

—

(3020650) Glucose [Presence] in Urine

135

0.81

0.22

2.3

1.9

0.00

0.04

estimate

0.80

135

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

26.91

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

0.00

0.21

0.0

1.1

—

1.00

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

0.08

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.21

0.0

1.4

—

0.48

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

102

0.78

0.21

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

1.78

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.01

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

108

1.20

0.20

2.5

2.3

5.00

332.88

ug/l

0.67

108

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

193

1.14

0.19

1.1

1.2

1.07

ratio

0.00

152

(40757373) Influenza virus identified in Isolate

1.22

0.19

2.1

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

118

1.19

0.19

1.2

2.1

1.36

6.95

ug/l

—

(3028626) Oxygen [Partial pressure] in Capillary blood

128

1223

1.05

0.18

2.9

3.2

8.11

7.96

kpa

0.68

128

1197

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

148

1.15

0.16

1.1

—

(3012501) Base excess in Blood by calculation

102

975

1.05

0.15

4.8

4.7

3.03

2.71

mmol/l

0.47

683

(3022806) Fractional oxyhemoglobin in Capillary blood

584

0.94

0.14

1.9

88.57

89.51

0.58

575

(3010726) Horse dander IgE Ab [Units/volume] in Serum

372

1.08

0.14

1.0

1.1

0.75

1.04

u/ml

0.28

191

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

104

1.15

0.12

1.5

1.6

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.18

0.12

1.4

1.3

297.20

386.67

u/l

—

(3035880) pH of Pleural fluid

307

1.08

0.12

1.3

1.4

7.39

7.40

0.06

207

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

116

0.86

0.12

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

374

0.94

0.11

1.1

1.0

64.15

43.15

ng/l

0.49

250

(40768800) Prostate Pathology biopsy report

110

1137

0.97

0.11

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

373

0.94

0.11

1.1

1.0

678.42

696.18

ng/l

0.07

247

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

189

1934

0.98

0.10

1.7

1.8

3.32

3.43

mmol/l

0.65

137

1397

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

372

0.94

0.10

1.1

1.0

286.21

321.29

ng/l

0.54

252

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.14

0.10

1.4

1.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.14

0.10

1.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

277

2725

1.02

0.09

2.0

2.1

3.26

3.43

ratio

1.79

225

2201

(3043410) Blood group antigens tested for on Red Blood Cells

124

0.89

0.09

1.1

2.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.11

0.09

3.8

1.4

—

0.76

—

(3028717) Thiamine [Mass/volume] in Blood

0.81

0.08

1.0

1.2

57.00

66.32

ug/l

—

(3024869) Neuronal Ab [Presence] in Serum

1.14

0.08

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

663

0.96

0.08

1.5

1.7

—

(40768795) Lymph node Pathology biopsy report

470

1.04

0.08

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

403

1.04

0.06

1.5

1.6

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

101

0.89

0.06

1.0

1.2

0.39

2.31

mmol/l

—

(3008295) Osmolality of Serum or Plasma

547

0.97

0.05

1.3

281.86

275.32

mosm/kgh2o

1.15

410

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

253

0.95

0.05

1.3

1.6

1243.01

1010.84

mu/l

0.39

205

(3038071) Oxygen [Partial pressure] in Mixed venous blood

109

0.92

0.04

8.0

7.4

4.67

5.41

kpa

—

109

(3018572) Chloride [Moles/volume] in Blood

107

1055

1.01

0.03

7.0

7.1

106.35

105.02

mmol/l

2.31

102

944

(3039000) Anion gap in Blood by calculation

107

1055

1.01

0.03

7.0

7.1

11.13

11.27

mmol/l

0.22

102

943

(1617658) Protocol used for examination of sentinel lymph nodes

330

1.03

0.03

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

122

1.07

0.02

1.3

1.2

13.15

12.44

mm/h

0.07

122

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

1.06

0.02

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

138

0.94

0.02

1.1

0.36

1.02

u/ml

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

228

0.96

0.02

1.2

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

491

4894

1.00

0.02

4.1

3.6

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

117

0.94

0.01

2.2

2.5

113.45

143.56

nmol/l

0.67

105

(3047181) Lactate [Moles/volume] in Blood

149

1499

0.99

0.01

6.1

1.22

1.32

mmol/l

1.05

139

1329

(3034426) Prothrombin time (PT)

122

0.98

0.00

1.1

1.3

27.25

28.71

0.54

122

(3001964) Herpes simplex virus Ag [Presence] in Specimen

122

0.98

0.00

2.0

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

105

1.05

0.00

1.1

1.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

125

1.04

0.00

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

125

1.04

0.00

1.0

1.23

2.05

u/ml

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

255

0.98

0.00

1.1

—

(3044007) Cell count panel - Peritoneal fluid

166

1.02

0.00

2.1

1.9

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

187

1.02

0.00

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

179

1.01

0.00

1.1

7.51

18.43

u/ml

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.00

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

25.80

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

106.67

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

4.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.00

-0.00

1.3

1.5

29.34

50.15

ug/l

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.7

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

1.51

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.91

-0.00

1.4

1.5

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

2.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.93

-0.00

1.8

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

0.93

-0.00

7.4

7.0

10.72

10.30

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.85

-0.00

1.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

7.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.95

-0.00

1.2

1.3

—

(4038314) Semen analysis, post vasectomy

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_CAECUM and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_CAECUM	1.248 [1.11, 1.4]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.036

During the follow-up period (1.1.1998 — 31.12.2019), 1399 out of 7195 females with CD2_BENIGN_CAECUM died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_CAECUM	1.395 [1.23, 1.58]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 1984 out of 6799 males with CD2_BENIGN_CAECUM died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_CAECUM.

N-year risk	Females	Males
1	0.101%	0.269%
5	0.735%	1.517%
10	1.712%	3.638%
15	3.252%	7.042%
20	5.608%	11.836%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_CAECUM – Benign neoplasm: Caecum

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Caecum

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints